<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">102900</article-id><article-id pub-id-type="doi">10.7554/eLife.102900</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.102900.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi–Goutières syndrome neuropathology</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nemec</surname><given-names>Kelsey M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3036-254X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Uy</surname><given-names>Genevieve</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chaluvadi</surname><given-names>V Sai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Purnell</surname><given-names>Freddy S</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Elfayoumi</surname><given-names>Bilal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Byerly</surname><given-names>Leila</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>O'Reilly</surname><given-names>Micaela L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Carleigh A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4549-0640</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Aisenberg</surname><given-names>William H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lombroso</surname><given-names>Sonia I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xinfeng</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Blank</surname><given-names>Niklas</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Oon</surname><given-names>Chet Huan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yaqoob</surname><given-names>Fazeela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Temsamrit</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rawat</surname><given-names>Priyanka</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Thaiss</surname><given-names>Christoph A</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bailis</surname><given-names>Will</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9420-6250</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Williamson</surname><given-names>Adam P</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qingde</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2482-7972</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bennett</surname><given-names>Mariko L</given-names></name><email>bennettm2@chop.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bennett</surname><given-names>F Chris</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2570-0620</contrib-id><email>frederick.bennett@pennmedicine.upenn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Division of Neurology, Children’s Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Biology, School of Arts and Sciences, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Epigenetics Institute, University of Pennsylvania, Perelman School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05sjwtp51</institution-id><institution>Department of Biology, Bryn Mawr College</institution></institution-wrap><addr-line><named-content content-type="city">Bryn Mawr</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>Department of Surgery, University of Pittsburgh School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Microbiology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0245cg223</institution-id><institution>Faculty of Biology, University of Freiburg</institution></institution-wrap><addr-line><named-content content-type="city">Freiburg im Breisgau</named-content></addr-line><country>Germany</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Neurology, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ginhoux</surname><given-names>Florent</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03vmmgg57</institution-id><institution>Singapore Immunology Network</institution></institution-wrap><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Diamond</surname><given-names>Betty</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dnene97</institution-id><institution>The Feinstein Institute for Medical Research</institution></institution-wrap><addr-line><named-content content-type="city">Manhasset</named-content></addr-line><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>27</day><month>01</month><year>2026</year></pub-date><volume>14</volume><elocation-id>RP102900</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-09-18"><day>18</day><month>09</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-09-20"><day>20</day><month>09</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.09.18.613629"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-06"><day>06</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102900.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-30"><day>30</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.102900.2"/></event></pub-history><permissions><copyright-statement>© 2025, Nemec et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Nemec et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-102900-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-102900-figures-v1.pdf"/><abstract><p>Microglia, the brain’s resident macrophages, can be reconstituted by surrogate cells – a process termed ‘microglia replacement’. To expand the microglia replacement toolkit, we here introduce estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized macrophages, a cell model for generation of immune cells from murine bone marrow, as a versatile model for microglia replacement. We find that ER-Hoxb8 macrophages are highly comparable to primary bone marrow-derived macrophages in vitro, and, when transplanted into a microglia-free brain, engraft the parenchyma and differentiate into microglia-like cells. Furthermore, ER-Hoxb8 progenitors are readily transducible by virus and easily stored as stable, genetically manipulated cell lines. As a demonstration of this system’s power for studying the effects of disease mutations on microglia in vivo, we created stable, Adar1-mutated ER-Hoxb8 lines using CRISPR-Cas9 to study the intrinsic contribution of macrophages to Aicardi–Goutières syndrome (AGS), an inherited interferonopathy that primarily affects the brain and immune system. We find that Adar1 knockout elicited interferon secretion and impaired macrophage production in vitro, while preventing brain macrophage engraftment in vivo – phenotypes that can be rescued with concurrent mutation of Ifih1 (MDA5) in vitro, but not in vivo. Lastly, we extended these findings by generating ER-Hoxb8 progenitors from mice harboring a patient-specific Adar1 mutation (D1113H). We demonstrated the ability of microglia-specific D1113H mutation to drive interferon production in vivo, suggesting microglia drive AGS neuropathology. In sum, we introduce the ER-Hoxb8 approach to model microglia replacement and use it to clarify macrophage contributions to AGS.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>microglia</kwd><kwd>microglia replacement</kwd><kwd>leukodystrophies</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021nxhr62</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE-1845298</award-id><principal-award-recipient><name><surname>Nemec</surname><given-names>Kelsey M</given-names></name><name><surname>Lombroso</surname><given-names>Sonia I</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH Medical Scientist Training Program</institution></institution-wrap></funding-source><award-id>T32 GM007170</award-id><principal-award-recipient><name><surname>Chaluvadi</surname><given-names>V Sai</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>T32-AG-000255-26</award-id><principal-award-recipient><name><surname>Chaluvadi</surname><given-names>V Sai</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xeg9z08</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>T32MH019112</award-id><principal-award-recipient><name><surname>Aisenberg</surname><given-names>William H</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04q48ey07</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>NIH T32 GM008076</award-id><principal-award-recipient><name><surname>Lombroso</surname><given-names>Sonia I</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/049hmt962</institution-id><institution>Blavatnik Family Foundation</institution></institution-wrap></funding-source><award-id>Blavatnik Family Fellowship</award-id><principal-award-recipient><name><surname>Lombroso</surname><given-names>Sonia I</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043z4tv69</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01AI139544</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Qingde</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS134651</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Qingde</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>DP5OD036159</award-id><principal-award-recipient><name><surname>Bennett</surname><given-names>Mariko L</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS120960</award-id><principal-award-recipient><name><surname>Bennett</surname><given-names>F Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q222b25</institution-id><institution>Esther A. and Joseph Klingenstein Fund</institution></institution-wrap></funding-source><award-id>Fellowship Award in Neuroscience</award-id><principal-award-recipient><name><surname>Bennett</surname><given-names>F Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01degd278</institution-id><institution>Paul Allen Frontiers Group</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bailis</surname><given-names>Will</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05h1kgg64</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>R35GM138085</award-id><principal-award-recipient><name><surname>Bailis</surname><given-names>Will</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05h1kgg64</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>R15NS133939</award-id><principal-award-recipient><name><surname>Williamson</surname><given-names>Adam P</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01degd278</institution-id><institution>The Paul Allen Frontiers Group</institution></institution-wrap></funding-source><award-id>GRT-00000774</award-id><principal-award-recipient><name><surname>Bennett</surname><given-names>F Chris</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A microglia replacement approach demonstrates that brain macrophages with patient mutations from Aicardi–Goutières syndrome, a genetic, brain predominant interferonopathy, are sufficient to drive interferon responses.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Microglia, the parenchymal tissue-resident macrophages of the brain and spinal cord, play critical roles in development, homeostasis, injury, and disease (<xref ref-type="bibr" rid="bib70">Salter and Stevens, 2017</xref>; <xref ref-type="bibr" rid="bib45">Li and Barres, 2018</xref>). When depleted of endogenous microglia, the brain parenchyma can be reconstituted by surrogate macrophages – a process termed ‘microglia replacement’. Microglia replacement has the potential for precise and personalized delivery of therapeutic payloads or correction of dysfunction. Primary microglia are challenging to manipulate – they rapidly lose transcriptional identity ex vivo, resist viral manipulation, are minimally proliferative, and are highly sensitive to serum (<xref ref-type="bibr" rid="bib7">Balcaitis et al., 2005</xref>; <xref ref-type="bibr" rid="bib42">Jiang et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Masuda et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Su et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Bohlen et al., 2017</xref>). These challenges limit the study of microglia replacement, underscoring the need for new, transplantable cell models. Common microglia surrogate cells include myeloid cells from the blood or bone marrow and induced pluripotent stem cell (iPSC)-derived microglia (iMG; <xref ref-type="bibr" rid="bib53">Muffat et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Pandya et al., 2017</xref>; <xref ref-type="bibr" rid="bib37">Haenseler et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Douvaras et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Abud et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Takata et al., 2020</xref>). Although capable of reconstituting the microglial niche (<xref ref-type="bibr" rid="bib59">Priller et al., 2001</xref>; <xref ref-type="bibr" rid="bib13">Bohlen et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">Hasselmann et al., 2019</xref>), primary cells and iPSCs each have limitations that motivated us to consider new microglia replacement tools.</p><p>To create an alternative microglia surrogate, we turned to the estrogen-regulated (ER) homeobox B8 (Hoxb8) system, a method for generating and gene-editing unlimited quantities of macrophages from primary murine bone marrow (<xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>). When overexpressed, Hoxb8 promotes the expansion of hematopoietic progenitor cells while preventing their differentiation. When transduced with ER-Hoxb8 virus, myeloid progenitor cells from murine bone marrow become immortalized and indefinitely expandable when in the presence of exogenous estrogen, but differentiate upon estrogen removal. The ER-Hoxb8 approach has been used to generate so-called ‘conditionally immortalized’ progenitors with lymphoid and myeloid potential (<xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib69">Rosas et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Redecke et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Gurzeler et al., 2013</xref>; <xref ref-type="bibr" rid="bib87">Zach et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Fites et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Ma et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Lail et al., 2022</xref>), including macrophages.</p><p>We recently showed that ER-Hoxb8 cells can reconstitute the microglial niche (<xref ref-type="bibr" rid="bib18">Chadarevian et al., 2023</xref>), supporting their potential as a new cell model for microglia replacement. Here, we aimed to deeply characterize the identity, function, and application of ER-Hoxb8s as microglia surrogates to test hypotheses about microglia-specific gene functions in health and disease.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Comparison of ER-Hoxb8 to bone marrow-derived macrophages in vitro</title><p>To directly compare primary bone marrow-derived (BMD) and ER-Hoxb8 cells, we created three biologically independent lines of conditionally immortalized macrophage progenitors as described previously (<xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>). ER-Hoxb8 progenitor cells were plated, differentiated for 7 days in CSF1, and compared to BMD macrophages (<xref ref-type="bibr" rid="bib75">Stanley and Heard, 1977</xref>; <xref ref-type="bibr" rid="bib54">Murray et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). We found that ER-Hoxb8 macrophages were highly similar to BMD macrophages morphologically (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and by CD11B/CD45 expression (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A/B</xref>). To validate ER-Hoxb8 macrophage function, we tested their phagocytic capacity. In agreement with prior literature (<xref ref-type="bibr" rid="bib27">Elhag et al., 2021</xref>), ER-Hoxb8 macrophages more efficiently engulfed beads coated with 10% phosphatidlyserine (PS) to mimic apoptotic cells, compared to beads coated with phosphatidylcholine (PC) alone (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C/D</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Comparison of ER-Hoxb8 to bone marrow-derived (BMD) macrophages in vitro.</title><p>(<bold>A</bold>) Schematic for creation of BMD and ER-Hoxb8 cells. (<bold>B</bold>) Brightfield images of BMD and ER-Hoxb8 macrophages plated in the presence of 30 ng/mL mouse CSF1 and differentiated for 7 days (scale bar = 100 um). (<bold>C</bold>) Dot plot representing CD45/CD11B levels (pre-gated on live, singlet, leukocyte) by flow cytometry. (<bold>D</bold>) Heatmap showing Log2 CPM of canonical macrophage (top) and non-macrophage (bottom) immune cell genes. (<bold>E</bold>) Whole-transcriptome comparison between BMD and ER-Hoxb8 macrophages, depicting best fit line and coefficient of determination (one dot = one gene). (<bold>F</bold>) Volcano plots comparing all genes or those with CPM &gt;1 (Log2FC ≥ 2, FDR &lt;0.05); blue = upregulated in ER-Hoxb8 macrophages, red = upregulated in BMD macrophages. Panel (<bold>A</bold>) created with <ext-link ext-link-type="uri" xlink:href="https://Biorender.com/w42j197">https://Biorender.com/w42j197</ext-link>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig1">Figure 1</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Extended validation and comparison of ER-Hoxb8 to bone marrow-derived (BMD) macrophages in vitro, relating to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Gating strategy for <xref ref-type="fig" rid="fig1">Figure 1C</xref>. (<bold>B</bold>) Flow cytometry histograms and median fluorescence intensity (MFI) of CD11B (left) and CD45 (right), relating to <xref ref-type="fig" rid="fig1">Figure 1C</xref>. (<bold>C</bold>) Merged image of ER-Hoxb8 macrophages (green) and synthetic apoptotic cell corpse mimics (10% PS beads, purple) imaged after fixation and staining (orange denotes beads counted as ingested). (<bold>D</bold>) Quantification of phagocytosis of synthetic apoptotic cell corpse mimics (10% PS beads) as compared to synthetic live cell mimic controls (PC beads); p-value calculated via nested <italic>t</italic>-test for n=4 replicates per group, with overall distribution (81–100 cells per replicate) shown in gray; ***p&lt;0.001. (<bold>E</bold>) Heatmap showing Log2 CPM gene expression levels of macrophage genes across groups; progenitor and macrophage groups are as represented in <xref ref-type="fig" rid="fig1">Figure 1A</xref>, BM Mono = monocytes isolated from BM, 4div ER-Hoxb8=ER-Hoxb8s collected after 4 days of in vitro differentiation. (<bold>F</bold>) PCA plot combining bulk RNA sequencing data amongst all groups. (<bold>G</bold>) Log2 CPM values of top 10 differentially expressed genes by Log2FC (CPM &gt;1, Log2FC ≥ 2, FDR &lt;0.05).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig1-figsupp1-v1.tif"/></fig></fig-group><p>To expand upon previous studies (<xref ref-type="bibr" rid="bib62">Redecke et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Roberts et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Accarias et al., 2020</xref>), we performed RNA sequencing of both cell types before and after 7 days of differentiation. We generated high-quality transcriptomes (Phred Score &gt;35, n=3 biological replicates) for BM progenitors, BM monocytes, 7-day differentiated BMD macrophages, ER-Hoxb8 progenitors, 4-day differentiated ER-Hoxb8 cells, and 7-day differentiated ER-Hoxb8 macrophages (top 100 expressed genes in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>). In agreement with previous literature (<xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>), ER-Hoxb8 progenitors express canonical macrophage genes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>) and, interestingly, ER-Hoxb8 cells at all time points were more similar to BMD macrophages than to BM progenitors or monocytes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</p><p>Transcriptionally, 7-day differentiated ER-Hoxb8 macrophages were highly similar to BMD macrophages as demonstrated by expression of macrophage-specific genes and lack of expression of common progenitor, lymphocyte, neutrophil, and natural killer cell-specific genes (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Linear regression analysis between the two cell types (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) revealed a strong correlation (R<sup>2</sup>=0.96) between expression levels of all 29,625 expressed genes. We identified 85 genes as differentially expressed between ER-Hoxb8 and BMD macrophages (FDR &lt;0.05, Log2 fold change ≥ 2, counts per million [CPM] &gt;1; <xref ref-type="fig" rid="fig1">Figure 1F</xref>). Of these, 74 were upregulated in BMD macrophages, 11 were upregulated in ER-Hoxb8 macrophages, and no statistically significant Gene Ontology (GO) terms were found for either group (top 10 DEGs by Log2FC in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>, all DEGs in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>). These data demonstrate that ER-Hoxb8 macrophages are highly similar to primary BMD macrophages in vitro.</p></sec><sec id="s2-2"><title>ER-Hoxb8 cells engraft the brain parenchyma after intracranial transplantation and attain a microglia-like identity</title><p>To extend the utility of the ER-Hoxb8 model, we next studied their engraftment and identity following intracranial transplantation into Csf1r<sup>-/-</sup> hosts, which lack microglia and readily permit donor cell engraftment (<xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). Using BMD cells as a primary cell control, early postnatal transplantation at days 0–5 (P0-5) led to robust and comparable parenchymal engraftment by 16 days (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>). ER-Hoxb8 macrophages engrafted at equivalent densities (171.7 cells/mm<sup>2</sup> ± 8.0) as endogenous, wild-type (WT) microglia (160.0 cells/mm<sup>2</sup> ± 5.5), while BMD macrophages engrafted at higher densities (264.6 cells/mm<sup>2</sup> ± 6.9; <xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Engraftment potential of ER-Hoxb8 compared to bone marrow-derived (BMD) macrophages after intracranial transplantation in Csf1r<sup>-/-</sup> hosts.</title><p>(<bold>A</bold>) Schematic for in vivo Csf1r<sup>-/-</sup> transplant experiments. (<bold>B</bold>) Rendered tile stitches of Csf1r<sup>-/-</sup> brains after intracranial injection of GFP+ bone marrow (left) or ER-Hoxb8 (right) progenitor cells. (<bold>C</bold>) Percent of total brain area tiled by donor cells; n=5–7 biological replicates per group; each dot = one biological replicate (average area across three matched sagittal sections). (<bold>D</bold>) Immunostaining of cortical brain region 12–16 days post-intracranial injection (red = IBA1, green = endogenous GFP, blue = DAPI; scale bar = 100 um; inset scale bar = 5 um). (<bold>E</bold>) Cortical density calculations (cells per mm<sup>2</sup>) between groups; n=5–7 biological replicates per group; each dot = one biological replicate (average density across three regions of interest across three matched sagittal sections). All p-values calculated via one-way ANOVA with multiple comparisons; ns = not significant or p≥0.05, ****p&lt;0.0001. Panel (<bold>A</bold>) created with <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/j85e198">https://BioRender.com/j85e198</ext-link>.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig2">Figure 2</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig2-v1.tif"/></fig><p>BMD macrophages become ‘microglia-like’ after engraftment in the Csf1r<sup>-/-</sup> brain (<xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>). Like BMD cells, ER-Hoxb8 cells lack expression of the microglia signature protein TMEM119 in vitro (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). After brain engraftment, we found comparably high levels of TMEM119 in BMD and ER-Hoxb8 macrophages by flow cytometry, though both had lower TMEM119 expression than endogenous microglia, consistent with prior studies (<xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Cronk et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Shemer et al., 2018</xref>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). As with WT microglia and BMD macrophages, ER-Hoxb8 macrophages likewise express P2RY12 after brain engraftment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>ER-Hoxb8 macrophages become microglia-like cells (MLCs) after engraftment in the Csf1r<sup>-/-</sup> brain.</title><p>(<bold>A</bold>) Histogram of TMEM119 surface staining by flow cytometry (pre-gated on live, singlet, leukocyte, CD45+/CD11B+) for brain-engrafted cells 14 days post-intracerebral transplantation; Mg = WT Microglia, BM = BMD MLCs, Hox = ER-Hoxb8 MLCs. (<bold>B</bold>) PCA plot comparing in vitro macrophages from <xref ref-type="fig" rid="fig1">Figure 1</xref> with in vivo macrophages; Mg = WT Microglia, BM = BMD MLCs, Hox = ER-Hoxb8 MLCs. (<bold>C</bold>) Whole-transcriptome comparison between WT microglia, BMD, and ER-Hoxb8 macrophages in vivo, depicting best fit line and the coefficient of determination. (<bold>D</bold>) Comparison of microglia signature genes (<xref ref-type="bibr" rid="bib23">Cronk et al., 2018</xref>) depicting best fit line and coefficient of determination. (<bold>E</bold>) In vitro and in vivo Log2 CPM gene expression of 10 canonical microglia/myeloid genes for bone marrow (left) and ER-Hoxb8s (right) as compared to unmanipulated in vivo microglia.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig3">Figure 3</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Extended comparison of ER-Hoxb8 and bone marrow-derived (BMD) macrophages after intracranial transplantation in Csf1r<sup>-/-</sup> hosts, relating to <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p>(<bold>A</bold>) Histogram of TMEM119 surface staining by flow cytometry (pre-gated on live, singlet, leukocyte, CD45+/CD11b+) for seven-day differentiated in vitro BMD and ER-Hoxb8 macrophages. (<bold>B</bold>) Immunostaining of cortical brain region 12–16 days post-intracranial injection (red = IBA1, green = endogenous GFP, white = P2RY12; blue = DAPI; scale bar = 100 um). (<bold>C</bold>) Gating strategy for in vivo TMEM119 histogram shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref> (pre-gated on live, singlet, leukocyte, GFP) of WT microglia and intracranially transplanted (ICT) cells (BM or ER-Hoxb8s). (<bold>D</bold>) Unsupervised hierarchical cluster dendrogram, related to <xref ref-type="fig" rid="fig3">Figure 3B</xref> (distance method = euclidean; cluster method = complete). (<bold>E</bold>) Comparison of ‘batch’ by PCA plots for harvest days (left), sorter used (middle), and host mouse sex (right). (<bold>F</bold>) Venn diagrams comparing the top 200 up- and downregulated genes, as compared to unmanipulated in vivo microglia; asterisk denotes data derived from previously published dataset (<xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>); genes were rank-ordered by absolute expression value, with only the top 1000 being considered for comparison, sorted by Log2FC &gt;2, FDR &lt;0.5, and ordered by Log2FC values. (<bold>G</bold>) Quantification of GFAP percent area covered; n=3 biological replicates per group; each dot = one biological replicate (average area across three matched sagittal sections); p-values calculated via one-way ANOVA with multiple comparisons; ns = not significant or p≥ 0.05. Panel (<bold>F</bold>) created with <ext-link ext-link-type="uri" xlink:href="https://Biorender.com/2k8tqf3">https://Biorender.com/2k8tqf3</ext-link>.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To more comprehensively assess microglial identity, we generated high-quality bulk RNA sequencing transcriptomes (Phred Score &gt;35; n=6–9 biological replicates, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) from isolated brain-engrafted BMD macrophages, ER-Hoxb8 macrophages, and endogenous microglia from age-matched WT hosts. Principal component analysis (PCA) and unsupervised hierarchical clustering revealed that brain residence induces both BMD and ER-Hoxb8 macrophages to become more similar to endogenous microglia (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). We saw no evidence for batch effects between harvest days, cell sorter used, or host mouse sex (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). BMD and ER-Hoxb8 microglia-like cells (MLCs) were transcriptionally similar, by both PCA and linear regression analysis (<xref ref-type="fig" rid="fig3">Figure 3B/C/D</xref>). ER-Hoxb8 MLCs upregulated expression of canonical microglia signature genes akin to BMD controls (P2ry12, Tmem119, Hexb, Fcrls, Gpr34, Olfml3, P2ry13, Sparc), including genes highly downregulated in vitro (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Like BMD macrophages, ER-Hoxb8 macrophages lack Sall1 expression in vivo compared to microglia (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Lastly, to more completely assess the degree that ER-Hoxb8 cells become ‘microglia-like’ after brain engraftment, we compared the top up- and downregulated genes from our datasets to those of brain-engrafted yolk sac (YS) progenitors using data from <xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C</xref>). We find overlap between groups, which likewise provides a better understanding of genes that are robustly regulated by brain engraftment. Taken together, these data show that, similar to BMD macrophages, ER-Hoxb8 macrophages become “microglia-like” with exposure to signals in the brain microenvironment.</p><p>Despite their similarities, BMD MLCs and ER-Hoxb8 MLCs have 650 differentially expressed genes (FDR &lt;0.05, Log2FC ≥ 2, and CPM &gt;1 in at least six of the samples (the ‘n’ of each group); <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1D</xref>). We performed statistical overrepresentation tests to identify relevant GO terms (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1E</xref>). Of particular interest were terms relating to biological processes as they concerned immune activity and reactivity. We discovered that the 34 overrepresented genes for these GO terms (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1F</xref>), were unique to ER-Hoxb8 MLCs, suggesting that the brain environment differentially affects engrafted BMD and ER-Hoxb8 cells, and that ER-Hoxb8 MLCs may be more primed to activation.</p><p>To gauge how significantly these transcriptomic increases in inflammation-associated genes impact the brain environment, we stained for GFAP, a marker of reactive astrocytosis and a sensitive marker for central nervous system (CNS) perturbations. We found no increase in GFAP expression across brain regions between any groups, including in brains engrafted with ER-Hoxb8 cells compared to BMD cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G</xref>).</p></sec><sec id="s2-3"><title><italic>Adar1</italic> mutation reduces macrophage number and induces interferon responses, effects mitigated by JAK inhibition or Ifih1 mutation</title><p>Having established ER-Hoxb8 macrophages as microglia-like cells, we explored their potential for study of microglia in health and disease. Building on prior work (<xref ref-type="bibr" rid="bib34">Gran et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Roberts et al., 2019</xref>; <xref ref-type="bibr" rid="bib1">Abud et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Bromberger et al., 2022</xref>; <xref ref-type="bibr" rid="bib73">Shen et al., 2022</xref>; <xref ref-type="bibr" rid="bib85">Xu et al., 2022</xref>; <xref ref-type="bibr" rid="bib51">Möller et al., 2023</xref>), we used CRISPR-Cas9 to knockout (KO) Tlr4 in Cas9<sup>+/-</sup> ER-Hoxb8 progenitors, using fluorescence-activated cell sorting (FACS) to establish lines of guide-transduced ER-Hoxb8 progenitors (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). We confirmed editing by TIDE analysis (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, <xref ref-type="bibr" rid="bib15">Brinkman et al., 2014</xref>) and protein loss by flow cytometry (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C/D</xref>). We then verified phenotypic knockout by treating unmodified, non-targeting control (NTC) guide-transduced, and Tlr4 guide-transduced ER-Hoxb8 macrophages with lipopolysaccharide (LPS, a Tlr4 agonist) or R848 (a Tlr7/8 agonist). As expected, Tlr4 KO blunted TNF-a production in response to Tlr4 but not Tlr7/8 agonism (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>).</p><p>Having validated effective gene targeting, we next leveraged strengths of the ER-Hoxb8 system to study the contribution of microglia to a monogenic CNS disease. Aicardi–Goutières syndrome (AGS) is a rare, brain-predominant genetic interferonopathy with nine known causal genes (<xref ref-type="bibr" rid="bib32">Gavazzi et al., 2024</xref>). As many cells respond to interferon, it is unclear which cells drive AGS brain pathology, particularly in cases where global gene knockout is embryonic lethal. We therefore tested the hypothesis that microglia, which produce and react strongly to interferons (<xref ref-type="bibr" rid="bib90">Zheng et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Aw et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Escoubas et al., 2024</xref>), are a main contributor to AGS pathology. We first confirmed that the seven coding AGS-causal genes are expressed by ER-Hoxb8 cells at similar levels to those of BMD cells and true microglia (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). We were primarily interested in Adar1, an RNA editing enzyme expressed by all brain cells, including microglia (<xref ref-type="bibr" rid="bib89">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Bennett et al., 2016</xref>). As ADAR1 loss disrupts hematopoiesis (<xref ref-type="bibr" rid="bib4">Arshadi et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Hartner et al., 2004</xref>), hematopoietic progenitor differentiation (<xref ref-type="bibr" rid="bib86">XuFeng et al., 2009</xref>), and is embryonically lethal in mice (<xref ref-type="bibr" rid="bib4">Arshadi et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Hartner et al., 2004</xref>), the impact of ADAR1 loss in macrophages is unknown. We leveraged the ER-Hoxb8 model to study Adar1 loss in macrophages by creating independent Adar1 KO lines using two distinct sgRNAs targeting different exons (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Adar1 mutation prevents macrophage-lineage cell expansion and causes interferon induction, rescued by JAKi or Ifih1 mutation.</title><p>(<bold>A</bold>) Schematic of ADAR1 locus, depicting exons, alternative start sites for p150 and p110 isoforms, and sgRNA targets. (<bold>B</bold>) ER-Hoxb8 cell counts over differentiation time course. (<bold>C</bold>) Immunostaining of in vitro, 8-day differentiated macrophages comparing control (NTC) and Adar1 guide-transduced macrophages (red = CD11B, blue = DAPI; scale bar = 100 um) (<bold>D</bold>) PCA plot of progenitors and macrophages in vitro (<bold>E</bold>) Volcano plots showing differentially expressed genes between Adar1 KO and NTC progenitors and macrophages (CPM &gt;1, Log2FC ≥ 2, FDR &lt;0.05). (<bold>F</bold>) Heatmap showing the Log2FC (Adar1 KO values over NTC values) for relevant interferon-stimulated genes. (<bold>G</bold>) Heatmap showing Log2 CPM of canonical macrophage (top) and non-macrophage (bottom) immune cell genes. (<bold>H</bold>) Heatmap showing Log2FC (Adar1 KO over NTC expression) for interferon-stimulated genes in macrophages treated with baricitinib. (<bold>I</bold>) ER-Hoxb8 cell counts over differentiation time course, comparing the effect of baricitinib on Adar KO and NTC lines (dosages = 0 uM, 0.00064 uM, 0.16 uM, 0.4 uM, and 10 uM); statistics calculated at the 9-day time point. (<bold>J</bold>) Interferon, cytokine, and chemokine production after treatment with baricitinib via cytokine bead array. (<bold>K</bold>) ER-Hoxb8 cell counts over differentiation time course, comparing NTC, Adar1 KO, and Adar/Ifih1 double KO (dKO) lines – dotted NTC and Adar1 KO lines are equivalent to those shown in panel (<bold>B</bold>). (<bold>L</bold>) Interferon, cytokine, and chemokine production via cytokine bead array, comparing NTC, Adar KO, and Adar/Ifih1 dKO lines. All p-values calculated via one-way (<bold>L</bold>) or two-way (<bold>B, I, J, K</bold>) ANOVA with multiple comparisons; ns = not significant or p≥0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig4">Figure 4</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>CRISPR-Cas9 editing of ER-Hoxb8 progenitors, relating to <xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>.</title><p>(<bold>A</bold>) Schematic for Tlr4 knockout using Cas9<sup>+/-</sup> ER-Hoxb8s and sgRNA viral transduction. (<bold>B</bold>) Post-editing trace decomposition charts (via TIDE Analysis) for Tlr4 KO macrophages. (<bold>C</bold>) Histogram of TLR4 surface staining by flow cytometry (pre-gated on live, singlet, leukocyte) for 8-day-differentiated in vitro BMD and ER-Hoxb8 macrophages. (<bold>D</bold>) TLR4 median fluorescence intensity (MFI) normalized to FMO levels using flow cytometry data shown in (C). (<bold>E</bold>) TNFa production, comparing control, LPS, and R848 treated samples (8-day differentiation, 9.5 h LPS or R848, 100 ng/mL, n=4 replicates per condition); p-values calculated via two-way ANOVA with multiple comparisons; ns = not significant or p≥0.05, ****p&lt;0.0001. Panel (<bold>A</bold>) created with <ext-link ext-link-type="uri" xlink:href="https://Biorender.com/q68t656">https://Biorender.com/q68t656</ext-link>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Evidence for gene knockout (KO), Adar1 sgRNA #2 results, and extended bead array data, relating to <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title><p>(<bold>A</bold>) Heatmap of Log2 CPM expression of seven causal AGS genes in BMD and ER-Hoxb8 macrophages. (<bold>B</bold>) Post-editing trace decomposition charts (via TIDE Analysis) for Adar1 KO cells targeted with two distinct guides. (<bold>C</bold>) ER-Hoxb8 cell counts over time. (<bold>D</bold>) Immunostaining of in vitro, 8-day-differentiated macrophages comparing control (NTC) and Adar1 sgRNA #2-transduced macrophages (red = CD11B, blue = DAPI; scale bar = 100 um). (<bold>E</bold>) Heatmap showing the Log2FC (Adar1 KO values over NTC values) for relevant interferon-stimulated genes for both progenitors and macrophages at baseline. (<bold>F</bold>) Validation of in vitro ER-Hoxb8 cell counts with vehicle or 10 uM baricitinib treatment using Adar1 sgRNA #2; statistics calculated at the 9-day time point. (<bold>G</bold>) Interferon, cytokine, and chemokine production for ER-Hoxb8 macrophages grown with or without baricitinib, via cytokine bead array. (<bold>H</bold>) Trace decomposition charts (via TIDE Analysis) for Adar1/Ifih1 double KO (dKO) cell lines. (<bold>I</bold>) Interferon, cytokine, and chemokine production for ER-Hoxb8 macrophages with or without subsequent Ifih1 KO. All p-values calculated via one-way (<bold>I</bold>) or two-way (<bold>C, F, G</bold>) ANOVA with multiple comparisons; ns = not significant or p≥0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****;p&lt;0.0001.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig4-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig4-figsupp2-v1.tif"/></fig></fig-group><p>We first explored differences during differentiation of Adar1 KO ER-Hoxb8 cells in vitro. Despite normal numbers at 3 days, there were significantly fewer Adar1 KO cells during the later stages of differentiation compared to NTC cells (<xref ref-type="fig" rid="fig4">Figure 4B/C</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C/D</xref>). This suggests that either Adar1 KO inhibits progenitor differentiation or macrophage proliferation and survival. We next performed RNA sequencing of Adar1 KO progenitors and differentiated macrophages. Adar1 KO progenitors were highly similar to NTC control progenitors (<xref ref-type="fig" rid="fig4">Figure 4D/E/F</xref>; all DEGs in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1G</xref>), and Adar1 KO macrophages expressed comparable levels of macrophage-identity genes to NTC (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), suggesting that Adar1 KO ER-Hoxb8 progenitors can generate macrophages. At the macrophage stage, however, we found 547 DEGs (<xref ref-type="fig" rid="fig4">Figure 4D/E/F</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1H</xref>), remarkable for interferon-stimulated gene (ISG) upregulation and GO term enrichment for responses to virus, stress, cytokine stimulation, and innate immunity (<xref ref-type="fig" rid="fig4">Figure 4E/F</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1I</xref>).</p><p>To test whether Adar1 KO-mediated interferon production underlies this macrophage phenotype, we used the Janus kinase (JAK) inhibitor Baricitinib to inhibit interferon signaling. Baricitinib, a treatment for AGS (<xref ref-type="bibr" rid="bib80">Vanderver et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Han et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Kanazawa et al., 2023</xref>), caused a dose-dependent reduction in ISG expression (<xref ref-type="fig" rid="fig4">Figure 4H</xref>) and normalized cell counts during macrophage differentiation (<xref ref-type="fig" rid="fig4">Figure 4I</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2F</xref>). We validated increased type I-specific interferon (IFN-b) and ISG (CXCL10, IL6, CCL5) production by Adar1 KO ER-Hoxb8 macrophages, and their suppression by baricitinib treatment using multiplex bead array (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). As interferons inhibit hematopoiesis and differentiation (<xref ref-type="bibr" rid="bib25">Demerdash et al., 2021</xref>), we confirmed that the baricitinib-treated cells were indeed macrophages (<xref ref-type="fig" rid="fig4">Figure 4G</xref>) and that the ISG reduction improved macrophage production.</p><p>Melanoma differentiation associated protein 5 (MDA5, or Ifih1) is an epistatic modifier of Adar1 such that deletion rescues some Adar1 phenotypes (<xref ref-type="bibr" rid="bib46">Liddicoat et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Guo et al., 2022</xref>). We introduced a guide targeting Ifih1 (BFP+) to Adar1 KO cells (GFP+). We created single-cell clones and validated double KO (dKO, GFP/BFP+) by TIDE analysis (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2H</xref>). Ifih1 loss completely rescued the Adar1 KO cell growth deficit during differentiation (<xref ref-type="fig" rid="fig4">Figure 4K</xref>), and normalized production of IFN-b, IL-6, and CCL5 (<xref ref-type="fig" rid="fig4">Figure 4L</xref>), but not CXCL10. As with baricitinib treatment (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2G</xref>), we found that multiple chemokines/cytokines are downregulated in Adar1-mutant cells as compared to NTC (TNF-a, IL-17, MIP-1a, MIP-1B, MIP-2, M-CSF), and are partially rescued by Ifih1 deletion (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2I</xref>).</p><p>Together, these data show that Adar1 deletion impairs macrophage but not progenitor health and is associated with interferonopathy, demonstrating the utility of the ER-HoxB8 model system for experimental isolation and study of macrophage dysfunction in a genetic disease.</p></sec><sec id="s2-4"><title><italic>Adar1</italic> mutation prevents ER-Hoxb8 engraftment</title><p>We next attempted to study how Adar1 KO macrophages affect the CNS. To our surprise, although TLR4 KO gene edited macrophages engrafted robustly (n=10; <xref ref-type="fig" rid="fig5">Figure 5A/E</xref>), mice injected with Adar1 KO cells died early and showed no engraftment in the brains of any transplanted mice that survived to endpoint (n=3; <xref ref-type="fig" rid="fig5">Figure 5B/C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Adar1 mutation prevents ER-Hoxb8 engraftment in the Csf1r<sup>-/-</sup> mouse, partially rescued by Ifih1 deletion.</title><p>(<bold>A</bold>) Representative rendering of donor cell engraftment (scale bar = 1000 um) with inset microscopy of GFP+ donor cell engraftment (green = endogenous GFP, blue = DAPI; scale bar = 100 um) for control cells (TLR4 KO and NTC) harvested 7–15 days post-injection (dpi), (<bold>B</bold>) Adar1 KO (sgRNA #1) cells (harvest details in <bold>E</bold>), (<bold>C</bold>) Adar1 KO (sgRNA #2) cells harvested 9-12dpi, and (<bold>D</bold>) Adar1/Ifih1 double KO (dKO) cells harvested 10–15 dpi (rendered dots in two right brains enlarged 5x for visualization). (<bold>E</bold>) Percent of total brain area tiled with cells between groups (numbers denote ‘n’ per group); Adar1 KO (#1) cells include pooled data (brains injected with 300k cells/hemisphere, harvested at 10–15 days post-injection (dpi; n=3); brains injected with 300k cells/hemisphere, harvested at 4–8 dpi (n=8); brains injected with 50k cells/hemisphere, harvested at 13 dpi (n=4); and brains injected with 100k cells/hemisphere pre-treated with 0.5 uM Baricitinib, mice treated daily with 1 mg/kg Baricitinib, harvested at 5 dpi (n=1)); asterisk indicates samples where engraftment is present but does not meet criteria for tiled brain area, as exemplified in (<bold>D</bold>); p-values calculated via one-way ANOVA with multiple comparisons; ns = not significant or p≥ 0.05, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig5">Figure 5</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Concurrent Adar1, Ifih1 mutation morphology, plus engraftment in the Cx3cr1CreERT; Csf1rfl/fl mouse, relating to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title><p>(<bold>A</bold>) Violin plot of all analyzed cortical ER-Hoxb8 cells (n=20) per animal (n=2), with yellow line denoting the median, for number of primary branches, average length of branches, longest branch length, and soma size; p-value calculated via nested <italic>t</italic>-test for n=2 animals per group; ns = not significant or p≥ 0.05, **p&lt;0.005. (<bold>B</bold>) Schematic for in vivo Cx3cr1CreERT; Csf1rfl/fl transplant experiments. (<bold>C</bold>) Representative rendering of donor cell engraftment (scale bar = 1000 um) with inset microscopy of GFP+ donor cell engraftment (green = endogenous GFP, blue = DAPI; scale bar = 100 um) for control cells (TLR4 KO, NTC) harvested 15 days post-injection, (<bold>D</bold>) Adar1 KO cells harvested seven days post-injection, (<bold>E</bold>) Adar1/Ifih1 double KO (dKO) cells harvested 13–15 days post-injection, and (<bold>F</bold>) Adar1 KO cells harvested 3 days post-injection. Panel (<bold>B</bold>) created with <ext-link ext-link-type="uri" xlink:href="https://Biorender.com/n75g136">https://Biorender.com/n75g136</ext-link>.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Because blocking interferon signaling with baricitinib or Ifih1 deletion correlated with better macrophage survival in vitro, we wondered if modifying our approach to limit interferon tone would permit Adar1 KO cell engraftment. We first reduced the number of injected cells (n=4) and harvested tissues earlier, between 4 and 8 days post-transplant (n=8), and did not observe engraftment. We then tried to pre-treat donor cells and host mice with Baricitinib and likewise did not observe engraftment in surviving mice (n=1; <xref ref-type="fig" rid="fig5">Figure 5E</xref>). Lastly, we transplanted Adar1/Ifih1 dKO cells (n=3), which showed partial rescue of Adar1 KO phenotypes in vitro. Although we detected no areas of engraftment meeting the stringent criteria applied for our ‘percent area’ quantification method, we noted diffuse patches of engrafted cells with rounded morphology and enlarged soma size, in three of three experimental replicates (<xref ref-type="fig" rid="fig5">Figure 5D/E</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), potentially consistent with a mild partial rescue of engraftment.</p><p>Csf1r<sup>-/-</sup> mice have severe constitutional, skeletal, and CNS abnormalities, typically succumbing by weaning age (<xref ref-type="bibr" rid="bib24">Dai et al., 2002</xref>). To extend our findings about Adar1 KO macrophages in vivo, we applied an inducible microglia depletion model using healthy Cx3cr1CreERT; Csf1rfl/fl hosts (<xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref>). After depleting endogenous microglia via subcutaneous tamoxifen injection at age P1 and P2, we intracerebrally transplanted cells into Cx3cr1CreERT; Csf1rfl/fl brains (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). After 7–15 days in vivo, we saw engraftment of control (TLR4 KO and NTC; n=4; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), but not Adar1 KO cells (n=5; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). Further mirroring the Csf1r<sup>-/-</sup> data, we saw small, diffuse patches of engrafted Adar1/Ifih1 dKO cells, but none reached quantifiable levels of engraftment (n=11; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). Lastly, we harvested transplanted Cx3cr1CreERT; Csf1rfl/fl hosts early, at day 3, and saw a diffuse pattern of non-quantifiable but parenchymally engrafted Adar1 KO cells (n=4; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>). These data suggest that Adar1 KO cells can enter the brain parenchyma but do not persist, consistent with the reduction in cell numbers observed in vitro during macrophage differentiation.</p><p>Overall, these results show that genetically modified ER-Hoxb8 cells robustly engraft in the brain parenchyma, which is prevented by Adar1 KO, independent of interferon production.</p></sec><sec id="s2-5"><title><italic>Adar1</italic> D1113H mutant ER-Hoxb8 macrophages drive brain ISG expression</title><p>Most available mouse models of AGS are either embryonic lethal (<xref ref-type="bibr" rid="bib4">Arshadi et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Hartner et al., 2004</xref>; <xref ref-type="bibr" rid="bib46">Liddicoat et al., 2015</xref>) or fail to produce CNS phenotypes (<xref ref-type="bibr" rid="bib52">Morita et al., 2004</xref>; <xref ref-type="bibr" rid="bib82">Ward et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Hiller et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Pereira-Lopes et al., 2013</xref>; <xref ref-type="bibr" rid="bib8">Behrendt et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Rehwinkel et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Ohto et al., 2022</xref>). We recently created a viable mouse model harboring a patient-derived mutation (D1113H) in the catalytic domain of ADAR1, which displays robust brain ISG expression, astrocytosis, microgliosis, and white matter calcifications (<xref ref-type="bibr" rid="bib35">Guo et al., 2022</xref>). Since AGS patient mutations are typically hypomorphic (rather than knockout), this more authentically models AGS (<xref ref-type="bibr" rid="bib64">Rice et al., 2014</xref>). Given the non-engraftment of Adar1 KO cells, we created ER-Hoxb8 cells from Adar1 D1113H mice to explore the impact of AGS-specific mutations in microglia. Unlike Adar1 KO cells, D1113H ER-Hoxb8s showed normal growth and expansion during in vitro differentiation (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), despite a similarly increased production of IFN-b, ISGs, and other cytokines, including CXCL10, CXCL1, CCL5, VEGF, MIP-1a, and MIP-1b, but not IFN-g (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Adar1 D1113H mutant ER-Hoxb8 macrophages persistently drive brain ISG expression.</title><p>(<bold>A</bold>) In vitro ER-Hoxb8 cell counts over time (p-values calculated via two-way ANOVA with multiple comparisons). (<bold>B</bold>) Multiplex bead array data for interferons, cytokines, and chemokines produced via ER-Hoxb8 macrophages (p-values calculated via independent two-sample <italic>t</italic>-test). (<bold>C</bold>) Sagittal sections of non-transplanted (tamoxifen [tam] sham control) Cx3cr1CreERT; Csf1rfl/fl brains (left) and Adar1 D1113H mutant brains (right) at age P15 and P28-31; nuclei (blue, DAPI), Isg15 (white via RNA in situ hybridization [ISH]); scale bar = 1000 um; red arrow depicts location of corresponding closeup images below, showing IBA1 (red, protein stain), Cre (green, ISH), Isg15 (purple, ISH), and nuclei (teal, DAPI); scale bar = 20 um; see <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref> for further corresponding closeup images. (<bold>D</bold>) Sagittal sections of Cx3cr1CreERT; Csf1rfl/fl brains intracranially transplanted with WT ER-Hoxb8s (left) and Adar1 D1113H ER-Hoxb8s (right) at 13 and 27 days post-injection (dpi); nuclei (blue, DAPI), Isg15 (white, ISH); scale bar = 1000 um; red arrow depicts location of corresponding closeup images below, showing IBA1 (red, protein stain), Cre (green, ISH), Isg15 (purple, ISH), and nuclei (teal, DAPI); scale bar = 20 um; see <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref> for further corresponding closeup images. All p-values characterized by: ns = not significant or p≥0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw numerical values for <xref ref-type="fig" rid="fig6">Figure 6</xref> plots.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-102900-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Evidence for Cre expression, relating to <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title><p>(<bold>A</bold>) Dual immunostaining/RNA in situ hybridization (ISH) showing IBA1 (red, protein stain), Cre (green, ISH), and nuclei (blue, DAPI); scale bar = 100 um (<bold>B</bold>) magnified image of a repopulated microglia from the non-transplanted (tam sham control) Cx3cr1CreERT; Csf1rfl/fl brain shown in (<bold>A</bold>); scale bar = 10 um.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Extended Isg15 RNA in situ hybridization (ISH), relating to <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title><p>(<bold>A</bold>) Dual immunostaining/RNA ISH showing IBA1 (red, protein stain), Isg15 (purple, ISH), and nuclei (teal, DAPI); scale bar = 100 um; white arrow depicts location of corresponding close up image; scale bar = 20 um. (<bold>B</bold>) Representative rendering of donor cell engraftment in the Csf1r<sup>-/-</sup> brain (scale bar = 1000 um) with inset microscopy of IBA1+ donor cell engraftment (red = IBA1, blue = DAPI; scale bar = 100 um) for FVB Osb-GFP WT ER-Hoxb8s and Adar1 D1113H mutant ER-Hoxb8s harvested 13–14 days post-injection. (<bold>C</bold>) Dual immunostaining/RNA ISH for samples shown in (<bold>B</bold>); tile scale bar = 1000 um; inset = Isg15 (pink, ISH), nuclei (blue, DAPI); scale bar = 100 um.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-102900-fig6-figsupp2-v1.tif"/></fig></fig-group><p>We next characterized D1113H ER-Hoxb8 cells after transplantation into the Cx3cr1CreERT; Csf1rfl/fl brain. As D1113H cells are not genetically tagged, we performed RNA in situ hybridization (ISH), using Cre expression (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A/B</xref>) to distinguish endogenous microglia (Cre+) from donor cells (Cre-). Unlike Adar KO cells, D1113H mutant ER-Hoxb8s engrafted the parenchyma (<xref ref-type="fig" rid="fig6">Figure 6C/D</xref>, n=5 biological replicates). Notably, both D1113H homozygous mutant brains (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) and mice engrafted with D1113H ER-Hoxb8 microglia-like cells exhibited similar and persistent upregulation in brain Isg15, with pockets of robust expression around engrafted Iba1+ MLCs, clustering around Iba1- nuclei that morphologically resemble neurons (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). To get a clearer idea of their overall engraftment potential, we transplanted D1113H mutant ER-Hoxb8s into Csf1r<sup>-/-</sup> mice, which are unconfounded by repopulating endogenous microglia. Similar to brains transplanted with Adar1/Ifih1 dKO cells, we found dispersed cell engraftment that did not reach quantifiable levels (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>, n=3 biological replicates). Consistent with results from Cx3cr1CreERT; Csf1rfl/fl host mice, we saw upregulation in brain Isg15 clustering around Iba1- nuclei (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>, n=3 biological replicates).</p><p>In sum, D1113H ER-Hoxb8 macrophages produce type I interferon and ISGs and induce Isg15 production by neighboring cells after brain engraftment. These results demonstrate that Adar1 mutation in microglia-like cells is sufficient to drive brain ISG production.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Realizing the potential of microglia replacement requires new tools for research and therapy development. Here, we show the power of estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized myeloid cells to robustly model microglia for rapid assessment of gene-targeted perturbations on their identity and function. We find that ER-Hoxb8 macrophages are similar to BMD macrophages both in vitro and in vivo, where they robustly engraft the microglia-deficient brain and upregulate microglial identity genes. We then use this model to demonstrate an approach to untangle macrophage contributions to a neurological disease, establishing the impact of macrophage-specific mutations to clinically relevant phenotypes both in vitro and in vivo.</p><p>Microglia are difficult to target and manipulate for preclinical study, necessitating the use of robust microglial surrogates for discovery, such as the ER-Hoxb8 system described here. Powerfully programmed by the brain environment, microglia lose their unique transcriptional identity in vitro (<xref ref-type="bibr" rid="bib13">Bohlen et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Gosselin et al., 2017</xref>) and are difficult to engineer (<xref ref-type="bibr" rid="bib55">O’Brien et al., 2022</xref>). Common surrogates include macrophages from isolated bone marrow or immortalized cell lines derived from macrophages or microglia (<xref ref-type="bibr" rid="bib75">Stanley and Heard, 1977</xref>; <xref ref-type="bibr" rid="bib60">Raschke et al., 1978</xref>; <xref ref-type="bibr" rid="bib79">Tsuchiya et al., 1980</xref>; <xref ref-type="bibr" rid="bib65">Righi et al., 1989</xref>; <xref ref-type="bibr" rid="bib12">Blasi et al., 1990</xref>; <xref ref-type="bibr" rid="bib19">Chanput et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Muffat et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Timmerman et al., 2018</xref>).</p><p>BMD cells are finite in number and exist as a heterogeneous population. Cell lines such as induced pluripotent stem cell-derived microglia-like cells can be expensive to generate and time-intensive to maintain (<xref ref-type="bibr" rid="bib78">Timmerman et al., 2018</xref>). ER-Hoxb8 cells are expandable, readily transducible, and brain-engraftable, making them a robust microglia surrogate. Building on the work of others (<xref ref-type="bibr" rid="bib67">Roberts et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Accarias et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Xu et al., 2022</xref>), we demonstrated straightforward gene editing using CRISPR-Cas9, generated stable lines using standard cell culture reagents, and found that ER-Hoxb8s are transcriptionally similar to primary BMD cells in vitro and in vivo. We used these strengths (and spared months of generating transgenic mouse lines) to readily test hypotheses about Adar1 function in microglia to demonstrate the potential of this system. We generated Adar1 knockout (KO) ER-Hoxb8 lines, as well as ER-Hoxb8 lines derived from mice harboring Adar1 patient mutations, to study the effect of microglia-specific Adar1 mutation on macrophage generation and interferon production. The ease with which ER-Hoxb8 cells can be modified, sorted, clonally expanded, banked, and transplanted was critical to these discoveries and will enable further innovation for the study of central nervous system macrophages.</p><p>In the future, the ER-Hoxb8 system will enable additional study of Adar1 and microglia in AGS. We found that both complete Adar1 KO, as well as an RNA-editing catalytic domain mutation in microglia-like cells, leads to increased interferon responses cell-autonomously in vitro, as well as non-cell-autonomously as demonstrated by direct transplant. This effect is blocked by Ifih1/MDA5 deletion, which is thought to sense abnormal RNA species formed by Adar1 mutation and rescues Adar1-catalytic domain point mutation phenotypes (<xref ref-type="bibr" rid="bib46">Liddicoat et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Guo et al., 2022</xref>). In contrast, brain engraftment is impacted by Adar1 KO regardless of Ifih1 genotype and not by Adar1 catalytic domain mutation, suggesting that the full KO phenotype may be independent of RNA editing and interferon production. Mitochondrial antiviral signaling (MAVS) adaptor protein rescues the embryonic lethality of Adar1 null mice (<xref ref-type="bibr" rid="bib48">Mannion et al., 2014</xref>), suggesting that manipulation of other Adar1 pathway components could reveal Adar1’s role in brain engraftment and macrophage maintenance. This system can allow for interrogation of alternative Adar1 functions, as well as other AGS mutations, and enables testing of AGS-targeted therapies.</p><p>All cell models have limitations, and we highlight two of particular relevance to the study of microglia. First, like primary BMD macrophages, ER-Hoxb8 macrophages derive from definitive as opposed to primitive hematopoiesis - the authentic origin of microglia. Though very similar to microglia, ER-Hoxb8s cannot attain full microglial identity, conspicuously lacking Sall1 expression, an important transcription factor in regulating homeostatic microglia (<xref ref-type="bibr" rid="bib17">Buttgereit et al., 2016</xref>). Second, we observe that ER-Hoxb8 macrophages express slightly higher levels of inflammation-associated genes than primary BMD macrophages after brain engraftment. Though insufficient to elicit GFAP upregulation, a sensitive biomarker for inflammation, it remains an important consideration for experimental design. Interestingly, a recent study suggests it may be possible to address both limitations by treating yolk sac progenitors with the ER-Hoxb8 virus to generate macrophages with reduced inflammatory reactivity that may serve as more authentic microglia surrogates (<xref ref-type="bibr" rid="bib27">Elhag et al., 2021</xref>). It also raises the exciting potential of an analogous system for study of human, patient-derived macrophages.</p><p>More broadly, the future of engineered microglia surrogates, including ER-Hoxb8 microglia-like cells, is bright. Leveraging the advantages of ER-Hoxb8 cells, one could create controllable gene editing via an inducible Cas9 or sgRNA and perform large, pooled screens in vitro and in vivo simultaneously, using progressively advanced methods for gene targeting. We envision microglia as potent neurotherapeutics (<xref ref-type="bibr" rid="bib11">Bennett and Bennett, 2020</xref>), and toward that goal, the ER-Hoxb8 model provides an ideal milieu for the testing of therapeutic cell engineering strategies, such as payload delivery, synthetic receptors, and customizable gene circuits. Here we applied two engraftment models, utilizing both Csf1r<sup>-/-</sup> and inducible Cx3cr1CreERT; Csf1rfl/fl host mice. Pairing the ER-Hoxb8 system with our CSF1R inhibitor-resistant receptor transplantation models will allow even more widespread adoption of these techniques (<xref ref-type="bibr" rid="bib18">Chadarevian et al., 2023</xref>). Together, the combination of accessible and modifiable microglial surrogates alongside increasingly effective transplantation models holds great potential for research and therapy development.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mouse models</title><p>All animal studies were performed with approval from the Children’s Hospital of Pennsylvania IACUC panel (#1326) in accordance with institutional and national regulations. All animals were housed in a non-barrier facility with 12 hour light/dark cycles at 23±2ºC in ventilated cages with no more than five animals per cage. Animals were provided water and standard chow ad libitum. Cages and bedding were changed weekly.</p><p>Csf1r<sup>-/-</sup> (FVB.129x1-Csf1rtm1Ers) and Csf1r<sup>+/+</sup> littermate animals on the FVB background were a generous gift from Dr. Richard Stanley (Albert Einstein College of Medicine). Cx3cr1CreERT; Csf1rfl/fl mice were generated by intercrossing JAX 021212 and 021160 strains. Adar D1113H mice (p.Asp1113His) were a generous gift from Dr. Qingde Wang (University of Pittsburgh). For experiments using GFP-expressing donor cells, we backcrossed Osb-GFP (C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ [JAX 006567]) onto FVB WT mice (JAX 001800) for 22 generations. For experiments using constitutively-expressed Cas9 donor cells, we used FVB.129(B6)-Gt(ROSA)26Sortm1.1(CAG-cas9*,-EGFP)Fezh/J mice (JAX 026558).</p></sec><sec id="s4-2"><title>In vitro experiments</title><sec id="s4-2-1"><title>ER-Hoxb8 conditionally immortalized cell production</title><p>Immortalization of murine myeloid progenitor cells was completed as outlined in <xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>. Briefly, bone marrow progenitors were isolated from the femurs and tibias of wildtype or Cas9-expressing FVB/NJ mice using a Percoll density separation (Cytiva, 17544501). Cells were cultured for three days in RPMI media (Invitrogen, 7240047) supplemented with 10 ng/mL IL3 (Peprotech, 213-13), IL6 (Peprotech, 216-16), and SCF (Peprotech, 250-03) before transduction with MSCVneo-HA-ER-Hoxb8 virus. Originally created by Dr. David Sykes (Massachusetts General Hospital), the MSCVneo-HA-ER-Hoxb8 plasmid was a generous gift from Dr. Igor Brodsky (University of Pennsylvania School of Veterinary Medicine). 24 hours after transduction, the cells were recovered and grown for 48 hours in RPMI media (Invitrogen, 7240047) supplemented with 1 mM Na-Pyruvate (Invitrogen, 11360070), 0.0005 mM beta-estradiol (Sigma Aldrich, E2758), and 10 ng/mL GM-CSF (Peprotech, 315-03). Cells were then selected for transduction with the addition of 1 mg/mL Geneticin (Thermo Fisher, 10131035) for 48 hours. Cells were then expanded and passaged every 48–72 hours at 25–50,000 cells/mL for 2 weeks, or until all non-immortalized cells were terminally differentiated or killed.</p></sec><sec id="s4-2-2"><title>Bone marrow isolations</title><p>Bone marrow harvests were completed as previously described (<xref ref-type="bibr" rid="bib9">Bennett et al., 2016</xref>). Briefly, femurs and tibias were dissected and flushed with 1x PBS to collect whole bone marrow. Red blood cells were then lysed with ACK Lysis Buffer (Quality Biological, 118-156-101). For experiments requiring bone marrow progenitors, whole bone marrow samples were subsequently enriched for lineage-negative cells using the Miltenyi Direct Lineage Cell Depletion Kit (130-110-470) via MACS Column separation with LS Columns (Miltenyi, 130-042-401). For experiments requiring bone marrow monocytes, whole bone marrow samples were subsequently enriched for monocytes using the Miltenyi Monocyte Isolation Kit (130-100-629) via MACS Column separation with LS Columns.</p></sec><sec id="s4-2-3"><title>Macrophage differentiation</title><p>Bone marrow-derived macrophages were differentiated in vitro by plating isolated bone marrow-derived progenitors in Petri dishes at a density of 5 million cells per dish in differentiation media – DMEM media (Thermo Fisher, 10569010), 10% FBS (VWR, 89510-186), 1% Penn/Strep (Invitrogen, 15140122), supplemented with 30 ng/mL murine M-CSF (Peprotech, 315-02). Cells were differentiated for 7–9 days in a 37°C incubator with 5% CO<sub>2</sub>, with media changes every 2–3 days.</p><p>ER-Hoxb8-derived macrophages were differentiated in vitro using methods adapted from <xref ref-type="bibr" rid="bib81">Wang et al., 2006</xref>. Briefly, ER-Hoxb8 progenitors were plated in petri dishes at a density of 2 million cells per dish, and then differentiated in the same media and timetable as noted above.</p></sec><sec id="s4-2-4"><title>Phagocytosis assay</title><p>C57BL/6 WT ER-Hoxb8 cells were differentiated for 7 days as described above. The day prior to the phagocytosis assay, cells were harvested via incubation with 3 mM EDTA, resuspended in macrophage differentiation media, diluted to 25,000 cells/mL in macrophage differentiation media, and plated in separate wells of 8 Chambered Coverglass Systems (CellVis, C8-1.5H-N; 500 µL cell dilution/12,500 cells per well). The phagocytosis assay was adapted from <xref ref-type="bibr" rid="bib84">Williamson and Vale, 2018</xref> and <xref ref-type="bibr" rid="bib31">Flannagan et al., 2014</xref>. Briefly, 10% phosphatidylserine (PS) beads were used to mimic apoptotic cell corpses and phosphatidylcholine (PC) beads were used to mimic live cells. 10% PS beads were 4.07 µm diameter silica beads (Bangs Labs, SS05002) coated in a supported lipid bilayer composed of 10 mol.% 18:1 PS (DOPS – Avanti, 840035), 89.90 mol.% 16:0-18:1 PC (POPC – Avanti, 850457), 0.1 mol.% atto390 dye-labeled DOPE (Atto-Tec, AD 390-161). PC beads were 4.07 µm diameter silica beads (Bangs Labs, SS05002) coated in a supported lipid bilayer composed of 99.90 mol.% 16:0-18:1 PC (POPC – Avanti, 850457), 0.1 mol.% atto390 dye-labeled DOPE (Atto-Tec AD 390-161). Beads were diluted to 500,000 beads/mL in macrophage differentiation media and added to the macrophages via media change, replacing old media with 500 uL bead dilution per chamber of the 8 Chambered Coverglass Systems. Macrophages were incubated with synthetic apoptotic cell corpse mimics or synthetic live cell mimics for 60 minutes at 37°C, 5% CO<sub>2</sub>. Cells were then fixed for 10 minutes at 37°C, 5% CO<sub>2</sub> in 4% paraformaldehyde (Sigma, P6148) in PBS, permeabilized for 1 minute in 0.1% TritonX-100 (Sigma, T8787) in PBS, and stained using HCS CellMask Green (Invitrogen, H32714). After staining, cells were placed under Aqua-Poly/Mount for imaging (Polysciences, 18606). Macrophages were imaged via spinning disk confocal microscopy on an inverted Nikon Ti2-E microscope fitted with a CSU-W1 spinning disk unit and Hamamatsu ORCA-FusionBT camera. Images were acquired using a 40x/0.95 NA objective in .nd2 format using Nikon Elements software and converted to ome-tif stacks for analysis in Fiji/ImageJ. Beads were considered ingested if HCS CellMask Green signal was visible fully surrounding a circular area inside the cell corresponding to the 4 µm diameter of the silica beads. Experiments were replicated four times on four different days using independently prepared reagents each day. 81–100 cells were examined per replicate condition.</p></sec><sec id="s4-2-5"><title>Viral production and transduction</title><p>To create retroviral supernatants, Lenti-X 293T cells (Takara Bio, 632180) were transfected using 850 ng/mL pCL-Eco (Addgene, 12371) and 850 ng/mL desired retroviral plasmid, supplemented with 5 uL/mL LipoD293 (SignaGen, 504782) in media containing DMEM (Thermo Fisher, 10569010), 25 mM HEPES (Invitrogen, 15630080), 10% FBS (VWR, 89510-186), and 1% Penn/Strep (Invitrogen, 15140122). Six hours post-transfection, media was replaced and viral supernatants were collected 48 and 72 hours later. Viral collections were combined and concentrated 10x using Retroviral Precipitation Solution (Alstem, VC200) according to manufacturer’s instructions.</p><p>Transduction of ER-Hoxb8 progenitors was completed in 12-well plates coated with 1 ug/mL fibronectin (Sigma-Aldrich, F1141). Cells were plated at 200,000 cells/mL and desired titer volume of virus was added. Plates were then spun for 90 minutes at 1000 × <italic>g</italic>. Post-spinfection, cells were gently mixed and resuspended in an additional 2–3 mL of fresh media. 24 hours post-transduction, cells were recovered and expanded at normal growing conditions (25–50,000 cells/mL at 37°C, 5% CO<sub>2</sub>).</p></sec><sec id="s4-2-6"><title>CRISPR editing</title><p>Target gene guide sequences were created using the Broad Institute’s CRISPick website (Mouse GRCm38 reference genome, CRISPRko mechanism, SpyoCas9 enzyme, tracrRNA) and adapted to ligate into our plasmid backbone. This backbone, which was a generous gift from Dr. Will Bailis (University of Pennsylvania; <xref ref-type="bibr" rid="bib6">Bailis et al., 2019</xref>) was adapted from the MSCV-MigR1-GFP/BFP plasmid (Addgene, 27490) to include a U6-driven gRNA scaffold for the insertion of guide sequences. The BbsI-HF restriction enzyme (NEB, R3539) was used to linearize the plasmid backbone at the gRNA scaffold site, and annealed guide oligos were ligated in. The ligated plasmids were then transformed using NEB Stable Cells (C3040), plated onto LB plates supplemented with 50 ug/mL ampicillin, and grown for 24 hours at 30°C. Correct insertion of guide sequences were confirmed using bacterial colony sanger sequencing via GeneWiz/Azenta, and full plasmid sequences were confirmed using Plasmidsaurus. Viral supernatants were then created as described above and Cas9-expressing ER-Hoxb8 macrophage progenitor cells were transduced as described above. Cells were then double-FACS sorted for transduction via fluorophore expression and expanded as normal. Successful editing was confirmed using TIDE as described in <xref ref-type="bibr" rid="bib15">Brinkman et al., 2014</xref>. Briefly, gDNA was collected from both control and experimental macrophages and the cut site was amplified via PCR and sent for Sanger sequencing. Indel creation was then confirmed via the TIDE application (<xref ref-type="bibr" rid="bib15">Brinkman et al., 2014</xref>; <ext-link ext-link-type="uri" xlink:href="http://shinyapps.datacurators.nl/tide/">http://shinyapps.datacurators.nl/tide/</ext-link>). When an antibody was commercially available, such as with TLR4 (Biolegend, 145403, PE), loss of protein was also confirmed via flow cytometry.</p><p>Guide oligo sequences:</p><list list-type="simple" id="list1"><list-item><p>Adar1 KO (sgRNA #1): <named-content content-type="sequence">GACACTGGCCAAGATTCCCA</named-content></p></list-item><list-item><p>Adar1 KO (sgRNA #2): <named-content content-type="sequence">TACCTGAACACCAACCCCGT</named-content></p></list-item><list-item><p>Ifih1 KO: <named-content content-type="sequence">TGTGGGTTTGACATAGCGCG</named-content></p></list-item><list-item><p>NTC: <named-content content-type="sequence">GCTTCCGCGGCCCGTTCAA</named-content></p></list-item></list><p>TIDE primer sequences:</p><list list-type="simple" id="list2"><list-item><p>Adar1 KO (sgRNA #1): <named-content content-type="sequence">CCATGTTGCCTTCTACAGGG</named-content>, <named-content content-type="sequence">GGGCAGAGGAGTTTGACAC</named-content></p></list-item><list-item><p>Adar1 KO (sgRNA #2): <named-content content-type="sequence">CAGAGGAAGCCATGAAGG</named-content>, <named-content content-type="sequence">ACACACGGTGACATTCATGC</named-content></p></list-item><list-item><p>Ifih1 KO: <named-content content-type="sequence">GCAGAGGACAGCTTCAGGA</named-content>, <named-content content-type="sequence">ATAGAAGGCTAGATGCAGCGG</named-content></p></list-item></list></sec><sec id="s4-2-7"><title>TNF-a ELISA</title><p>ER-Hoxb8 progenitor cells were plated and differentiated as described in the above ‘Macrophage Differentiation’ methodology. After 7 days in vitro, cells were gently removed from the Petri dishes using ice cold 1x PBS + 2 mM EDTA (Thermo Fisher, 15575020). Cells were then re-plated at 50,000 cells/well in a TC-treated 96-well plate in 100 uL fresh differentiation media. 24 hours later, LPS (Sigma, L2880-25MG) and R848 (Invitrogen, TLRL-R848) were added at 100 ng/mL to respective wells. After 9.5 hours, supernatants were collected and diluted to 25% initial concentration to stay within kit ranges. TNF-a concentrations were measured using the TNF alpha Mouse Uncoated ELISA Kit with Plates (ThermoFisher, 88-7324-22) according to manufacturer’s instructions.</p></sec><sec id="s4-2-8"><title><italic>Adar1</italic> immunofluorescence</title><p>ER-Hoxb8 progenitor cells were plated and differentiated as described in the above ‘Macrophage Differentiation’ methodology. NTC and Adar1-edited cells were plated at 5000 cells per well in a glass-bottom 96-well plate. Cells were fixed on day eight of differentiation in 4% PFA (EMS, 15714) for 10 minutes. Cells were washed, blocked in 0.1% Tween20 (Bio-Rad, 1706531) + 5% donkey serum (Sigma, S39-100ML) for 1 hour, and then stained overnight with CD11B (BioLegend, 101208) and Hoescht 33342 Solution (Thermo Fisher, 66249) at 4°C. The following morning, cells were washed and imaged at 40x magnification Z-stacks using a BZ-X800 (Keyence) microscope.</p></sec><sec id="s4-2-9"><title><italic>Adar1</italic> cell quantification</title><p>ER-Hoxb8 progenitor cells were plated and differentiated as described in the above ‘Macrophage Differentiation’ methodology. NTC and Adar1-edited cells were plated at 5000 cells per well in glass-bottom 96-well plates (n=3 independently differentiated replicates per condition). Cells were plated in fresh differentiation media supplemented with nothing, vehicle (DMSO), or 10 uM Baricitinib (Selleck Chemicals, S2851). Cells were plated with 125 uL media on day 0, 62.5 uL media was added on day 3, media was removed and replaced with 100 uL media on day 6. On differentiation days 0, 3, 6, and 9, corresponding subsets of cells were stained with 1:10,000 Hoescht for 30 minutes at 37°C and imaged with the ImageXpress Micro Confocal System. Images were taken at 10x magnification at nine sites per well, with exposure settings consistent between wells. Cell number quantification was performed using the ‘Count Nuclei’ pipeline in the ImageXpress software. Signal thresholds were set, masks were created over the Hoescht+ signal, and nuclei were counted (3–16 pixel width). Cell counts were averaged across the nine imaging sites and plotted as average nuclei per field per day of differentiation.</p></sec><sec id="s4-2-10"><title><italic>Adar1</italic> multiplex arrays</title><p>ER-Hoxb8 progenitor cells were plated and differentiated as described in the above ‘Macrophage Differentiation’ methodology. NTC and Adar1-edited cells (Adar1 KO #1, Adar1 KO #3, Adar1/Ifih1 dKO) were plated at 100,000 cells per well in an untreated 24-well plate (n=4 independently differentiated replicates per condition), whereas WT and D1113H cells were plated at 25,000 cells per well in an untreated 24-well plate (n=4 independently differentiated replicates per condition). Media was changed every 2 days, with the baricitinib groups receiving 0 uM, 0.00064 uM, 0.16 uM, 0.4 uM, or 10 uM Baricitinib (Selleck Chemicals, S2851) with each media change. On day 7 of differentiation (24hours post final media change), cell supernatant was collected, spun down, and immediately frozen. Multiplexing analysis was performed using the Luminex 200 system by Eve Technologies Corp. (Calgary, Alberta). Assays used include the Mouse Cytokine/Chemokine 44-Plex Discovery Assay Array (MD44), the Mouse Cytokine/Chemokine 32-Plex Discovery Assay Array (MD32), as well as the Mouse IFN-a + IFN-b Assay (MDIFNAB). For the baricitinib groups, RNA was immediately collected from adherent cells for subsequent sequencing analyses.</p></sec></sec><sec id="s4-3"><title>In vivo experiments</title><sec id="s4-3-1"><title>Neonatal transplantation</title><p>For intracranial transplantation into Csf1r<sup>-/-</sup> mice, p0-p5 pups were randomly assigned and injected as previously described (<xref ref-type="bibr" rid="bib13">Bohlen et al., 2017</xref>) by hand using a pulled glass capillary tube (World Precision Instruments, 1B100F-4) in an electrode holder connected by silicon tubing to a syringe. One microliter containing a single-cell suspension (300,000 cells/uL unless otherwise noted) of donor cells in 1x PBS was slowly injected bilaterally into cortex, 1–2 mm anterior and 2–3 mm lateral to lambda at a depth of 0.5–1 mm. Host animals were harvested 12–16 days after injection unless otherwise noted.</p></sec><sec id="s4-3-2"><title>Microglia/MLC isolations</title><p>Single-cell suspensions of microglia/engrafted brain macrophages were isolated as previously described (<xref ref-type="bibr" rid="bib9">Bennett et al., 2016</xref>). Briefly, mice were anesthetized using a cocktail of ketamine (100 mg/kg) plus xylazine (10 mg/kg) in 1x PBS and perfused with 10 mL cold PBS. Brains were dounce homogenized in 10 mL cold Medium A Buffer – 10% 10x HBSS (Fisher, 14185052), 1.5% 1 M HEPES (Invitrogen, 15630080), 1.67–30% glucose (Sigma, G7021-1KG), 86.8% ddH<sub>2</sub>O supplemented with 2% DNase (Worthington, LS002007). Homogenate was filtered through a 70 um strainer and pelleted. Microglia were collected following a spin with isotonic percoll – 10% 10x HBSS, 90% Percoll PLUS density gradient media (GE Healthcare, 17544501). Cells were washed with Medium A Buffer and resuspended in desired media. Mice were excluded from the study if they did not survive to the predetermined harvest timepoint.</p></sec><sec id="s4-3-3"><title>In vivo baricitinib treatment</title><p>Baricitinib (Selleckchem, S2851) was reconstituted in DMSO (Sigma-Aldrich, D26250) and added to a diluent of 40% PEG300 (Sigma-Aldrich, 90878), 10% Tween80 (Sigma-Aldrich, P1754), and 50% water. Mice were administered 20 uL daily by intraperitoneal injection at doses of 10 mg/kg, 5 mg/kg, or 1 mg/kg.</p></sec></sec><sec id="s4-4"><title>Staining experiments</title><sec id="s4-4-1"><title>Immunofluorescence</title><p>Mice were perfused with 15 mL 1x PBS followed by 15 mL 4% PFA (EMS, 15714) and organs were then drop-fixed in 4% PFA for 16–24 hours at 4°C. Organs were then cryo-protected in 30% sucrose (Neta Scientific, SIAL-S5391-25KG), embedded in OCT (Fisher, 23-730-571), cryo-sectioned at 16 um, mounted on Superfrost Plus slides (Fisher, 1255015), and frozen at –80°C. Slides were then thawed at 60°C, rehydrated in 1x PBS, and blocked for 1 hour at RT in blocking buffer – 90% 1x PBS, 9.5% donkey serum (Sigma, S39-100ML), 0.5% Triton X-100 (Sigma, T8787-50ML). After blocking, slides were incubated with primary antibodies (described below) in staining buffer (98.5% 1x PBS, 1% donkey serum, 0.5% Triton X-100) overnight at 4°C. In the morning, slides were washed with 1x PBS and incubated with secondary antibodies (described below) for 1 hour at RT in staining buffer. Slides were washed once more and coverslipped with DAPI mounting media (EMS, 17989–60) before imaging.</p><p>Antibodies used: rabbit Anti-Iba1 (Fujifilm, 019-19741, 1:500); mouse Anti-GFAP (Agilent, MAB360, 1:500); donkey anti-rabbit IgG 594 (Thermo Fisher, A-21207, 1:500); donkey anti-mouse IgG 647 (Thermo Fisher, A32787, 1:500).</p></sec><sec id="s4-4-2"><title>RNA in situ hybridization</title><p>In situ hybridization (ISH) was performed on mounted fixed frozen tissues using the RNAscope system per the manufacturer’s protocol (Advanced Cell Diagnostics). Fluorescent detection was achieved using the RNAscope Multiplex Fluorescent Detection kit V2 (cat # 323110). Samples were probed for mouse Isg15 (cat # 559271-C2) and Cre (cat # 312281-C3) and visualized with TSA Vivid dyes (cat #s 7534 and 7536). Following ISH, slides were immunostained with rabbit anti-Iba1 (cat # 019-19741, Fujifilm WAKO) and detected using fluorescently labeled donkey anti-rabbit secondary antibody (A21207, Invitrogen). Slides were coverslipped and nuclei were stained with Prolong Gold Antifade Mounting Medium with DAPI (cat # P36931, Invitrogen).</p></sec><sec id="s4-4-3"><title>Imaging acquisition and processing</title><p>Slides were imaged using a BZ-X800 (Keyence) microscope. Whole-organ tile images plus z-stack images were captured and stitched/compressed using Keyence Analyzer software prior to image export. All images within experiment panels were taken with equivalent exposure settings. All images were then analyzed with FIJI (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link>), equivalently adjusting only for brightness and black values (raw images available upon request).</p><p>Engraftment renderings were created using GFP (488) or Iba1 (594) and DAPI channels of 10x stitches. Background was equivalently subtracted using the ‘subtract background’ function before manually thresholding via the ‘otsu’ setting. Rendered dot masks were created by analyzing particles (size = 2–144 px; circularity = 0.5–1.0) and overlaying them on the corresponding DAPI channel. The boundaries of the brains were then outlined using the ‘polygon selections’ tool, and everything outside this boundary was cleared and excluded from the final image.</p><p>16 um tissue sections used for RNA scope were imaged using an Andor BC43 spinning disc confocal microscope (Oxford Instruments). Sections that were directly compared were acquired using the same exposure, laser power, gain, and resolution settings. Subsequently, image analysis on raw unmanipulated images was performed using Imaris software. Representative images displayed for publication were processed equally in Imaris across all conditions to best display the data.</p></sec><sec id="s4-4-4"><title>Percent area quantifications</title><p>For each brain sample, average total engrafted area was calculated from three matched sagittal sections (200 uM apart starting at the medial-most point of the tissue), each using a 4x tile-scan image collected via Keyence microscope. Calculations were made in FIJI using the Iba1 and/or GFP channel tiled images. FIJI’s ‘polygon selections’ tool and ‘measure’ function were used to draw and calculate a total brain ROI, as well as engrafted area ROI(s). The latter were defined as regions with Iba1+ and/or GFP+ cell groups with no fewer than 50 total cells per ‘group’ nor 50 cells/mm<sup>2</sup>. Edge limits of engraftment areas were defined by the nucleus of the edge-most cell being no more than 200 uM from nearest-neighbor cells. Percent area engrafted was then calculated by dividing total engrafted area(s) by total brain area. Olfactory bulb was omitted for consistency as it was not present in all samples.</p><p>For each brain sample, average total area of GFAP+ cells was calculated from three matched sagittal sections (250 uM apart starting at the medial-most point of the tissue), each using a 10x tile-scan image collected via Keyence microscope. Calculations were made in FIJI using the GFAP channel tiled images. Background was equivalently subtracted from all images using the ‘subtract background’ function. Images were then converted into 8-bit format and thresholded at 40/255 with the ‘intermodes’ setting. ROIs were manually drawn for cortex, hippocampus, midbrain, and thalamus using FIJI’s ‘polygon selections’ tool. Percent area covered was then calculated using the ‘measure’ function to quantify positive GFAP signal over total ROI area.</p></sec><sec id="s4-4-5"><title>Cell density quantification</title><p>For each brain sample, average cortical cell density was calculated using the same three matched sagittal sections used above to calculate area of engraftment. Here, three 20x representative images were included that spanned the cortical region of engraftment. If the region of engraftment was small, fewer images were included such that no cells overlapped and were counted more than once. Cells were counted manually using FIJI’s ‘Cell Counter’ tool and were defined as cells that were Iba1+ and/or GFP+ and directly overlaid with a DAPI+ nucleus. Cell counts per image were averaged and divided by total area per image to obtain densities at cells/mm<sup>2</sup>.</p></sec><sec id="s4-4-6"><title>Morphological analysis</title><p>All morphological analyses were performed using Fiji. Individual Iba1+ cells in the cortical parenchyma were randomly selected from 10x stitched images of the brain. For all images, individual cells were converted to 8-bit and thresholded equivalently. The despeckle function was used to remove noise from each sample. Each image was then converted to a binary image that was used for further analysis. Soma size was measured by drawing a region of interest (ROI) around somas and measuring the encompassed area. Primary branches were defined as branches extending directly from the soma and were counted manually. The length of each branch was measured from the center of the cell soma using the Neuroanatomy SNT plugin (<xref ref-type="bibr" rid="bib4">Arshadi et al., 2021</xref>). Traces were drawn to outline branch morphology, then measured using the SNT Measurements function to obtain branch lengths.</p></sec><sec id="s4-4-7"><title>Flow cytometry and FACS</title><p>Once isolated into single cell suspensions, cells were washed 2x in FACS Buffer - 1x PBS, 0.5% BSA (Sigma, 126609-10GM), 0.5 mM EDTA (Thermo Fisher, 15575020) – and blocked with FC Block – 0.2% CD16/CD32 (BD Biosciences, 553142) in FACS Buffer – for 10 minutes at RT. Cells were then stained using antibodies (described below) for 30–60 minutes at 4°C. Cells were washed 2x more in FACS Buffer before being analyzed or sorted as described below.</p><p>Antibodies used: LIVE/DEAD fixable far red dead cell stain kit (Invitrogen, L10120, 1:1600); anti-mouse CD45 (PE/Cyanine7, Clone 30-F11, Biolegend, 103113, 1:400); anti-mouse/human CD11b (PerCP/Cyanine5.5, Clone M1/70, Biolegend, 101227, 1:400); anti-mouse monoclonal TMEM119 (PE, Clone V3RT1GOsz, Invitrogen, 12-6119-82, 1:400).</p><p>For flow cytometry experiments, stained cells were analyzed on a CytoFLEX LX (6 Laser) Flow Cytometer and visualized via FlowJo (10.8.1). For sorting experiments, stained cells were sorted with a 100 uM nozzle on a FACSAria Fusion, FACSJazz, Aurora, or MoFlo Astrios depending on Core availability (no effects on data were seen between FACS machines). Cells were deposited into media for cell expansion, or TRIzol LS Reagent (Fisher, 10296028) for subsequent RNA extraction.</p></sec></sec><sec id="s4-5"><title>Bulk RNA-sequencing and analysis</title><sec id="s4-5-1"><title>RNA extraction and quantification</title><p>For in vitro populations, RNA was extracted using the Qiagen RNeasy Mini Kit (74104) according to manufacturer’s instructions. For suspended populations, cells were collected and spun down at 200 × <italic>g</italic> for 5 minutes, supernatant was removed, and 350 uL Buffer RLT was added directly to the cell pellet. For adherent populations, supernatant was removed, plates were washed with 1x PBS, and 650 uL of Buffer RLT was added directly to the dish to create cell lysates.</p><p>For in vivo populations, cells were isolated as described in the above ‘Microglia/MLC Isolations’ methodology and FACS sorted into TRIZol LS reagent as described in the above ‘Flow Cytometry and FACS’ methodology. Cells were briefly vortexed and 0.2 volumes of chloroform (Sigma, C2432-500ML) were added. Cells were again vortexed, incubated for 3 minutes at RT, and then centrifuged at 12,000 x <italic>g</italic> for 15 minutes at 4°C. The upper aqueous phase was then collected and 1 volume of fresh 70% EtOH was added. Cells were again vortexed and then run through the Qiagen RNeasy Micro Kit (74004) according to manufacturer’s instructions. Isolated RNA was stored at –80°C.</p><p>When able, RNA Integrity Numbers (RINs) were calculated using an Agilent TapeStation with High Sensitivity RNA ScreenTape (5067-5579) and Sample Buffer (5067-5580) according to manufacturer’s instructions. Cells with a RIN ≥ 7.5 were used for subsequent library preparations. For in vitro datasets, the average RIN score was 9.03. Quantification was often not possible for brain-isolated cell populations due to low yield. In this case, all samples were used for subsequent library preparations, and quality was assessed later during preparation.</p></sec><sec id="s4-5-2"><title>Library preparation and sequencing</title><p>Sequencing libraries were prepared in-house using either 40 ng or 8 uL RNA per sample, depending on if RIN scores and concentrations were able to be calculated as discussed above, using the NEBNext Single Cell/Low Input RNA Library Prep Kit for Illumina (NEB, E6420) according to manufacturer’s instructions. Quality and quantity steps were performed using an Agilent TapeStation using High Sensitivity D5000 ScreenTape (5067-5592), and High Sensitivity D5000 Reagents (5067*-5593).</p><p>Bulk RNA-sequencing of completed libraries was performed by the Children’s Hospital of Philadelphia’s Center for Applied Genomics (CAG) Core Facility using a NovaSeq 6000 (Illumina) system with the SP Reagent Kit v1.5 (2 × 100 bp). Data was de-multiplexed and sent to us as FastQ files via BaseSpace (Illumina).</p><p>For sequencing of NTC and Adar1-edited cells with varying doses of Baricitinib, cDNA libraries were sent to Novogene for sequencing using a NovaSeq 6000 (Illumina) system with the S4 Reagent Kit (2 × 150 bp). Data was de-multiplexed and sent to us as FastQ files for manual download. Data sequenced by Novogene was never combined with data sequenced by CAG.</p></sec><sec id="s4-5-3"><title>Sequencing analysis</title><p>All pre-processing steps were run using Terminal. FastQ files were downloaded from BaseSpace (Illumina) and concatenated across lanes using the ‘cat‘ function. All files were processed using FastP (<xref ref-type="bibr" rid="bib21">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Chen, 2023</xref>) to filter reads and trim Illumina adaptors, as well as FastQC (<xref ref-type="bibr" rid="bib3">Andrews, 2014</xref>) to assess quality. All files were determined to be of sufficient quality for subsequent downstream processing. Reads were pseudoaligned to the mouse GRCm39 cDNA transcriptome (Ensembl release 99; <xref ref-type="bibr" rid="bib71">Schneider et al., 2017</xref>; <xref ref-type="bibr" rid="bib88">Zerbino et al., 2018</xref>) using Kallisto (version 0.46.0; <xref ref-type="bibr" rid="bib14">Bray et al., 2016</xref>) and run through MultiQC (<xref ref-type="bibr" rid="bib29">Ewels et al., 2016</xref>) for a final quality check after mapping.</p><p>All post-processing steps were run using RStudio (<xref ref-type="bibr" rid="bib61">R Development Core Team, 2022</xref>). Transcripts were summarized to the gene level through tximport (version 1.14.2; <xref ref-type="bibr" rid="bib74">Soneson et al., 2015</xref>) with abundance counts calculated via TPM and then normalized using TMM via edgeR (<xref ref-type="bibr" rid="bib68">Robinson et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">McCarthy et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Chen et al., 2016</xref>). Hierarchical cluster dendrograms were created using the ‘dist’function (method = euclidean) and ‘hclust’ function (method = complete) and were visualized with the plot function. PCA plots were created using the ‘prcomp’ function. Differential gene expression analysis was performed using linear modeling via limma (<xref ref-type="bibr" rid="bib66">Ritchie et al., 2015</xref>), and differentially expressed genes (DEGs) were decided by applying an FDR cutoff of 0.05, a counts per million (CPM) cutoff of +1, and a Log2(FC) cutoff of ±2. Linear models and R<sup>2</sup> values were created using the ‘lm’ function. All output plots were visualized with ggplot2 (<xref ref-type="bibr" rid="bib83">Wickham, 2016</xref>).</p><p>Statistical overrepresentation tests and related GO Terms were calculated using the Panther Classification System (version 18.0). Respective lists of DEGs were manually imported into the Gene List Analysis tab, selected for <italic>Mus musculus</italic>, and run through the statistical overrepresentation test option using the PANTHER GO-Slim options for biological process, molecular function, and cellular component. Tests were run using the Fisher’s Exact option while calculating the false discovery rate. FDR was set to a threshold of 0.05, and terms were ranked via the hierarchy option.</p></sec></sec><sec id="s4-6"><title>Statistical calculations</title><p>GraphPad Prism (version 10.0.0) was used to perform statistical tests and generate p values with standard designations (ns = not significant or p≥0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001). All values are shown as mean ± standard error of the mean (SEM). Details regarding replicate numbers and individual statistical test used are provided in the respective figure legends. No explicit power analyses were performed, but group size was based on previous studies using similar approaches. Blinding was used whenever possible, such as for all cell quantifications, morphology analyses, and multiplex arrays.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Supervision, Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con8"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con9"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Investigation</p></fn><fn fn-type="con" id="con12"><p>Investigation</p></fn><fn fn-type="con" id="con13"><p>Investigation</p></fn><fn fn-type="con" id="con14"><p>Investigation</p></fn><fn fn-type="con" id="con15"><p>Investigation</p></fn><fn fn-type="con" id="con16"><p>Formal analysis, Visualization</p></fn><fn fn-type="con" id="con17"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Resources, Supervision</p></fn><fn fn-type="con" id="con19"><p>Conceptualization, Resources, Formal analysis, Supervision, Validation, Investigation</p></fn><fn fn-type="con" id="con20"><p>Conceptualization, Resources, Supervision</p></fn><fn fn-type="con" id="con21"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal studies were performed with approval from the Children's Hospital of Pennsylvania IACUC panel (#1326) in accordance with institutional and national regulations. All animals were housed in a non-barrier facility with 12-hour light/dark cycles at 23+/-2 degrees C in ventilated cages with no more than five animals per cage. Animals were provided water and standard chow ad libitum. Cages and bedding were changed weekly.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-102900-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Spreadsheet of RNA-sequencing data and GO Terms.</title></caption><media xlink:href="elife-102900-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Raw microscopy images used for rendered tile stitches, RNAScope, and IHC/ICC panels.</title></caption><media xlink:href="elife-102900-supp2-v1.zip" mimetype="application" mime-subtype="zip"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data used to support the claims of this study are included in the manuscript and supporting files. Source data files have been provided for all figures. Raw and processed files of bulk RNA-sequencing data have been deposited at Gene Expression Omnibus under accession GSE314288. Sequencing data used from <xref ref-type="bibr" rid="bib10">Bennett et al., 2018</xref> and <xref ref-type="bibr" rid="bib23">Cronk et al., 2018</xref> are publicly available at their corresponding citations.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Kelsey</surname><given-names>MN</given-names></name><name><surname>Genevieve</surname><given-names>U</given-names></name><name><surname>Freddy</surname><given-names>SP</given-names></name><name><surname>Bilal</surname><given-names>E</given-names></name><name><surname>Leila</surname><given-names>B</given-names></name><name><surname>Micaela</surname><given-names>LO</given-names></name><name><surname>Carleigh</surname><given-names>AO</given-names></name><name><surname>William</surname><given-names>HA</given-names></name><name><surname>Sonia</surname><given-names>IL</given-names></name><name><surname>Xinfeng</surname><given-names>G</given-names></name><name><surname>Niklas</surname><given-names>B</given-names></name><name><surname>Chet Huan</surname><given-names>O</given-names></name><name><surname>Fazeela</surname><given-names>Y</given-names></name><name><surname>Brian</surname><given-names>T</given-names></name><name><surname>Priyanka</surname><given-names>R</given-names></name><name><surname>Christoph</surname><given-names>AT</given-names></name><name><surname>Will</surname><given-names>B</given-names></name><name><surname>Adam</surname><given-names>PW</given-names></name><name><surname>Qingde</surname><given-names>W</given-names></name><name><surname>Mariko</surname><given-names>LB</given-names></name><name><surname>Chaluvadi</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutières Syndrome neuropathology</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314288">GSE314288</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Cronk</surname><given-names>JC</given-names></name><name><surname>Filiano</surname><given-names>AJ</given-names></name><name><surname>Louveau</surname><given-names>A</given-names></name><name><surname>Marin</surname><given-names>I</given-names></name><name><surname>March</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>E</given-names></name><name><surname>Goldman</surname><given-names>DH</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Geraci</surname><given-names>N</given-names></name><name><surname>Acton</surname><given-names>S</given-names></name><name><surname>Overall</surname><given-names>CC</given-names></name><name><surname>Kipnis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84819">GSE84819</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Cronk</surname><given-names>JC</given-names></name><name><surname>Filiano</surname><given-names>AJ</given-names></name><name><surname>Louveau</surname><given-names>A</given-names></name><name><surname>Marin</surname><given-names>I</given-names></name><name><surname>March</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>E</given-names></name><name><surname>Goldman</surname><given-names>DH</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Geraci</surname><given-names>N</given-names></name><name><surname>Acton</surname><given-names>S</given-names></name><name><surname>Overall</surname><given-names>CC</given-names></name><name><surname>Kipnis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia [GFP]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108569">GSE108569</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Cronk</surname><given-names>JC</given-names></name><name><surname>Filiano</surname><given-names>AJ</given-names></name><name><surname>Louveau</surname><given-names>A</given-names></name><name><surname>Marin</surname><given-names>I</given-names></name><name><surname>March</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>E</given-names></name><name><surname>Goldman</surname><given-names>DH</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Geraci</surname><given-names>N</given-names></name><name><surname>Acton</surname><given-names>S</given-names></name><name><surname>Overall</surname><given-names>CC</given-names></name><name><surname>Kipnis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia [LPS]</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108575">GSE108575</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>A combination of ontogeny and environment establishes microglial identity</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA453419">PRJNA453419</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Richard Stanley (Albert Einstein College of Medicine, New York, NY, USA) for the Csf1r<sup>−/−</sup> (FVB.129X1-Csf1rtm1Ers) and Csf1r<sup>+/+</sup> littermate animals on the FVB background; Dr. Qingde Wang (University of Pittsburgh, Pittsburgh, PA, USA) for the Adar1 D1113H mice (p.Asp1113His); Dr. David Sykes (Mass General Hospital, Boston, MA, USA) and Dr. Igor Brodsky (University of Pennsylvania, Philadelphia, PA, USA) for the MSCVneo-HA-ER-HoxB8 plasmid; Dr. Dan Beiting for the bulk RNA sequencing DIY Transcriptomics scripts; the Children’s Hospital of Philadelphia Center for Applied Genomics for bulk RNA sequencing assistance; the Children’s Hospital of Philadelphia Flow Cytometry core for flow cytometry and sorting assistance; <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">https://www.biorender.com/</ext-link> for graphics; and Kayla Peelman (Emory University, Atlanta, GA, USA) for assistance with Illustrator. This work was supported by National Science Foundation Graduate Research Fellowship Program DGE-1845298 (KMN, SIL); NIH Training in Age Related Neurodegenerative Diseases T32 2-T32-AG-000255–26 (VSC); NIH Medical Scientist Training Program T32 GM007170 (VSC); NIH T32MH019112 (WHA); NIH T32 GM008076 (SIL); Blavatnik Family Fellowship, Blavatnik Foundation (SIL); NIH R35GM138085 (WB); Paul Allen Institute Distinguished Investigator Award (WB); NIH R15NS133939 (APW); R01AI139544 (QW); R01NS134651 (QW); NIH DP5OD036159 (MLB); NIH R01-NS-120960–01 (FCB); Klingenstein-Simons Fellowship in Neuroscience (FCB); and The Paul Allen Frontiers Group GRT-00000774 (FCB). Since the submission of this manuscript, we lost our colleague and dear friend, Dr. Qingde Wang, a leader in the field of ADAR research. We wish to acknowledge his important contributions to this work, his generous mentorship of our trainees, and his lasting impact on the field. He is deeply missed.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abud</surname><given-names>EM</given-names></name><name><surname>Ramirez</surname><given-names>RN</given-names></name><name><surname>Martinez</surname><given-names>ES</given-names></name><name><surname>Healy</surname><given-names>LM</given-names></name><name><surname>Nguyen</surname><given-names>CHH</given-names></name><name><surname>Newman</surname><given-names>SA</given-names></name><name><surname>Yeromin</surname><given-names>AV</given-names></name><name><surname>Scarfone</surname><given-names>VM</given-names></name><name><surname>Marsh</surname><given-names>SE</given-names></name><name><surname>Fimbres</surname><given-names>C</given-names></name><name><surname>Caraway</surname><given-names>CA</given-names></name><name><surname>Fote</surname><given-names>GM</given-names></name><name><surname>Madany</surname><given-names>AM</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Gylys</surname><given-names>KH</given-names></name><name><surname>Cahalan</surname><given-names>MD</given-names></name><name><surname>Cummings</surname><given-names>BJ</given-names></name><name><surname>Antel</surname><given-names>JP</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Carson</surname><given-names>MJ</given-names></name><name><surname>Poon</surname><given-names>WW</given-names></name><name><surname>Blurton-Jones</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>iPSC-derived human microglia-like cells to study neurological diseases</article-title><source>Neuron</source><volume>94</volume><fpage>278</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.042</pub-id><pub-id pub-id-type="pmid">28426964</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accarias</surname><given-names>S</given-names></name><name><surname>Sanchez</surname><given-names>T</given-names></name><name><surname>Labrousse</surname><given-names>A</given-names></name><name><surname>Ben-Neji</surname><given-names>M</given-names></name><name><surname>Boyance</surname><given-names>A</given-names></name><name><surname>Poincloux</surname><given-names>R</given-names></name><name><surname>Maridonneau-Parini</surname><given-names>I</given-names></name><name><surname>le Cabec</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genetic engineering of Hoxb8-immortalized hematopoietic progenitors - a potent tool to study macrophage tissue migration</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs236703</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.236703</pub-id><pub-id pub-id-type="pmid">31964707</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>FastQC a Quality-Control Tool for High-Throughput Sequence Data</article-title><ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link><date-in-citation iso-8601-date="2026-01-18">January 18, 2026</date-in-citation></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arshadi</surname><given-names>C</given-names></name><name><surname>Günther</surname><given-names>U</given-names></name><name><surname>Eddison</surname><given-names>M</given-names></name><name><surname>Harrington</surname><given-names>KIS</given-names></name><name><surname>Ferreira</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SNT: a unifying toolbox for quantification of neuronal anatomy</article-title><source>Nature Methods</source><volume>18</volume><fpage>374</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01105-7</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aw</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Carroll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microglial responses to peripheral type 1 interferon</article-title><source>Journal of Neuroinflammation</source><volume>17</volume><elocation-id>340</elocation-id><pub-id pub-id-type="doi">10.1186/s12974-020-02003-z</pub-id><pub-id pub-id-type="pmid">33183319</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailis</surname><given-names>W</given-names></name><name><surname>Shyer</surname><given-names>JA</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Maher</surname><given-names>LJ</given-names></name><name><surname>Canaveras</surname><given-names>JCG</given-names></name><name><surname>Al Khazal</surname><given-names>FJ</given-names></name><name><surname>Qu</surname><given-names>R</given-names></name><name><surname>Steach</surname><given-names>HR</given-names></name><name><surname>Bielecki</surname><given-names>P</given-names></name><name><surname>Khan</surname><given-names>O</given-names></name><name><surname>Jackson</surname><given-names>R</given-names></name><name><surname>Kluger</surname><given-names>Y</given-names></name><name><surname>Rabinowitz</surname><given-names>J</given-names></name><name><surname>Craft</surname><given-names>J</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function</article-title><source>Nature</source><volume>571</volume><fpage>403</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1311-3</pub-id><pub-id pub-id-type="pmid">31217581</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balcaitis</surname><given-names>S</given-names></name><name><surname>Weinstein</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chamberlain</surname><given-names>JS</given-names></name><name><surname>Möller</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Lentiviral transduction of microglial cells</article-title><source>Glia</source><volume>50</volume><fpage>48</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1002/glia.20146</pub-id><pub-id pub-id-type="pmid">15625717</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrendt</surname><given-names>R</given-names></name><name><surname>Schumann</surname><given-names>T</given-names></name><name><surname>Gerbaulet</surname><given-names>A</given-names></name><name><surname>Nguyen</surname><given-names>LA</given-names></name><name><surname>Schubert</surname><given-names>N</given-names></name><name><surname>Alexopoulou</surname><given-names>D</given-names></name><name><surname>Berka</surname><given-names>U</given-names></name><name><surname>Lienenklaus</surname><given-names>S</given-names></name><name><surname>Peschke</surname><given-names>K</given-names></name><name><surname>Gibbert</surname><given-names>K</given-names></name><name><surname>Wittmann</surname><given-names>S</given-names></name><name><surname>Lindemann</surname><given-names>D</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Dahl</surname><given-names>A</given-names></name><name><surname>Naumann</surname><given-names>R</given-names></name><name><surname>Dittmer</surname><given-names>U</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Mueller</surname><given-names>W</given-names></name><name><surname>Gramberg</surname><given-names>T</given-names></name><name><surname>Roers</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response</article-title><source>Cell Reports</source><volume>4</volume><fpage>689</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.07.037</pub-id><pub-id pub-id-type="pmid">23972988</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Ajami</surname><given-names>B</given-names></name><name><surname>Zamanian</surname><given-names>JL</given-names></name><name><surname>Fernhoff</surname><given-names>NB</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Bohlen</surname><given-names>CJ</given-names></name><name><surname>Adil</surname><given-names>A</given-names></name><name><surname>Tucker</surname><given-names>A</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name><name><surname>Chang</surname><given-names>EF</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Grant</surname><given-names>GA</given-names></name><name><surname>Hayden Gephart</surname><given-names>MG</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>New tools for studying microglia in the mouse and human CNS</article-title><source>PNAS</source><volume>113</volume><fpage>E1738</fpage><lpage>E1746</lpage><pub-id pub-id-type="doi">10.1073/pnas.1525528113</pub-id><pub-id pub-id-type="pmid">26884166</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>FC</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Yaqoob</surname><given-names>F</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Grant</surname><given-names>GA</given-names></name><name><surname>Hayden</surname><given-names>MG</given-names></name><name><surname>Plowey</surname><given-names>ED</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A combination of ontogeny and CNS environment establishes microglial identity</article-title><source>Neuron</source><volume>98</volume><fpage>1170</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.05.014</pub-id><pub-id pub-id-type="pmid">29861285</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The influence of environment and origin on brain resident macrophages and implications for therapy</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>157</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0545-6</pub-id><pub-id pub-id-type="pmid">31792468</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasi</surname><given-names>E</given-names></name><name><surname>Barluzzi</surname><given-names>R</given-names></name><name><surname>Bocchini</surname><given-names>V</given-names></name><name><surname>Mazzolla</surname><given-names>R</given-names></name><name><surname>Bistoni</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus</article-title><source>Journal of Neuroimmunology</source><volume>27</volume><fpage>229</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/0165-5728(90)90073-v</pub-id><pub-id pub-id-type="pmid">2110186</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohlen</surname><given-names>CJ</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name><name><surname>Tucker</surname><given-names>AF</given-names></name><name><surname>Collins</surname><given-names>HY</given-names></name><name><surname>Mulinyawe</surname><given-names>SB</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures</article-title><source>Neuron</source><volume>94</volume><fpage>759</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.043</pub-id><pub-id pub-id-type="pmid">28521131</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>NL</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Melsted</surname><given-names>P</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Near-optimal probabilistic RNA-seq quantification</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>525</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nbt.3519</pub-id><pub-id pub-id-type="pmid">27043002</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkman</surname><given-names>EK</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Amendola</surname><given-names>M</given-names></name><name><surname>van Steensel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Easy quantitative assessment of genome editing by sequence trace decomposition</article-title><source>Nucleic Acids Research</source><volume>42</volume><elocation-id>e168</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gku936</pub-id><pub-id pub-id-type="pmid">25300484</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bromberger</surname><given-names>T</given-names></name><name><surname>Klapproth</surname><given-names>S</given-names></name><name><surname>Sperandio</surname><given-names>M</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Humanized β2 integrin-expressing Hoxb8 cells serve as model to study integrin activation</article-title><source>Cells</source><volume>11</volume><elocation-id>11091532</elocation-id><pub-id pub-id-type="doi">10.3390/cells11091532</pub-id><pub-id pub-id-type="pmid">35563841</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttgereit</surname><given-names>A</given-names></name><name><surname>Lelios</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Vrohlings</surname><given-names>M</given-names></name><name><surname>Krakoski</surname><given-names>NR</given-names></name><name><surname>Gautier</surname><given-names>EL</given-names></name><name><surname>Nishinakamura</surname><given-names>R</given-names></name><name><surname>Becher</surname><given-names>B</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sall1 is a transcriptional regulator defining microglia identity and function</article-title><source>Nature Immunology</source><volume>17</volume><fpage>1397</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/ni.3585</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadarevian</surname><given-names>JP</given-names></name><name><surname>Lombroso</surname><given-names>SI</given-names></name><name><surname>Peet</surname><given-names>GC</given-names></name><name><surname>Hasselmann</surname><given-names>J</given-names></name><name><surname>Tu</surname><given-names>C</given-names></name><name><surname>Marzan</surname><given-names>DE</given-names></name><name><surname>Capocchi</surname><given-names>J</given-names></name><name><surname>Purnell</surname><given-names>FS</given-names></name><name><surname>Nemec</surname><given-names>KM</given-names></name><name><surname>Lahian</surname><given-names>A</given-names></name><name><surname>Escobar</surname><given-names>A</given-names></name><name><surname>England</surname><given-names>W</given-names></name><name><surname>Chaluvadi</surname><given-names>S</given-names></name><name><surname>O’Brien</surname><given-names>CA</given-names></name><name><surname>Yaqoob</surname><given-names>F</given-names></name><name><surname>Aisenberg</surname><given-names>WH</given-names></name><name><surname>Porras-Paniagua</surname><given-names>M</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Davtyan</surname><given-names>H</given-names></name><name><surname>Spitale</surname><given-names>RC</given-names></name><name><surname>Blurton-Jones</surname><given-names>M</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Engineering an inhibitor-resistant human CSF1R variant for microglia replacement</article-title><source>The Journal of Experimental Medicine</source><volume>220</volume><elocation-id>e20220857</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20220857</pub-id><pub-id pub-id-type="pmid">36584406</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanput</surname><given-names>W</given-names></name><name><surname>Mes</surname><given-names>JJ</given-names></name><name><surname>Wichers</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>THP-1 cell line: an in vitro cell model for immune modulation approach</article-title><source>International Immunopharmacology</source><volume>23</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.08.002</pub-id><pub-id pub-id-type="pmid">25130606</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lun</surname><given-names>ATL</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline</article-title><source>F1000Research</source><volume>5</volume><elocation-id>89872</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.8987.2</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastp</article-title><source>iMeta</source><volume>2</volume><elocation-id>107</elocation-id><pub-id pub-id-type="doi">10.1002/imt2.107</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronk</surname><given-names>JC</given-names></name><name><surname>Filiano</surname><given-names>AJ</given-names></name><name><surname>Louveau</surname><given-names>A</given-names></name><name><surname>Marin</surname><given-names>I</given-names></name><name><surname>Marsh</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>E</given-names></name><name><surname>Goldman</surname><given-names>DH</given-names></name><name><surname>Smirnov</surname><given-names>I</given-names></name><name><surname>Geraci</surname><given-names>N</given-names></name><name><surname>Acton</surname><given-names>S</given-names></name><name><surname>Overall</surname><given-names>CC</given-names></name><name><surname>Kipnis</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia</article-title><source>The Journal of Experimental Medicine</source><volume>215</volume><fpage>1627</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1084/jem.20180247</pub-id><pub-id pub-id-type="pmid">29643186</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X-M</given-names></name><name><surname>Ryan</surname><given-names>GR</given-names></name><name><surname>Hapel</surname><given-names>AJ</given-names></name><name><surname>Dominguez</surname><given-names>MG</given-names></name><name><surname>Russell</surname><given-names>RG</given-names></name><name><surname>Kapp</surname><given-names>S</given-names></name><name><surname>Sylvestre</surname><given-names>V</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects</article-title><source>Blood</source><volume>99</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1182/blood.v99.1.111</pub-id><pub-id pub-id-type="pmid">11756160</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demerdash</surname><given-names>Y</given-names></name><name><surname>Kain</surname><given-names>B</given-names></name><name><surname>Essers</surname><given-names>MAG</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Yin and Yang: The dual effects of interferons on hematopoiesis</article-title><source>Experimental Hematology</source><volume>96</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2021.02.002</pub-id><pub-id pub-id-type="pmid">33571568</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douvaras</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Kruglikov</surname><given-names>I</given-names></name><name><surname>Lallos</surname><given-names>G</given-names></name><name><surname>Zimmer</surname><given-names>M</given-names></name><name><surname>Terrenoire</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Gandy</surname><given-names>S</given-names></name><name><surname>Schadt</surname><given-names>E</given-names></name><name><surname>Freytes</surname><given-names>DO</given-names></name><name><surname>Noggle</surname><given-names>S</given-names></name><name><surname>Fossati</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Directed differentiation of human pluripotent stem cells to microglia</article-title><source>Stem Cell Reports</source><volume>8</volume><fpage>1516</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.04.023</pub-id><pub-id pub-id-type="pmid">28528700</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elhag</surname><given-names>S</given-names></name><name><surname>Stremmel</surname><given-names>C</given-names></name><name><surname>Zehrer</surname><given-names>A</given-names></name><name><surname>Plocke</surname><given-names>J</given-names></name><name><surname>Hennel</surname><given-names>R</given-names></name><name><surname>Keuper</surname><given-names>M</given-names></name><name><surname>Knabe</surname><given-names>C</given-names></name><name><surname>Winterhalter</surname><given-names>J</given-names></name><name><surname>Gölling</surname><given-names>V</given-names></name><name><surname>Tomas</surname><given-names>L</given-names></name><name><surname>Weinberger</surname><given-names>T</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wagner</surname><given-names>F</given-names></name><name><surname>Lorenz</surname><given-names>M</given-names></name><name><surname>Stark</surname><given-names>K</given-names></name><name><surname>Häcker</surname><given-names>H</given-names></name><name><surname>Schmidt-Supprian</surname><given-names>M</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Jastroch</surname><given-names>M</given-names></name><name><surname>Lauber</surname><given-names>K</given-names></name><name><surname>Straub</surname><given-names>T</given-names></name><name><surname>Walzog</surname><given-names>B</given-names></name><name><surname>Hammer</surname><given-names>E</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Differences in cell-intrinsic inflammatory programs of yolk sac and bone marrow macrophages</article-title><source>Cells</source><volume>10</volume><elocation-id>10123564</elocation-id><pub-id pub-id-type="doi">10.3390/cells10123564</pub-id><pub-id pub-id-type="pmid">34944072</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escoubas</surname><given-names>CC</given-names></name><name><surname>Dorman</surname><given-names>LC</given-names></name><name><surname>Nguyen</surname><given-names>PT</given-names></name><name><surname>Lagares-Linares</surname><given-names>C</given-names></name><name><surname>Nakajo</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>SR</given-names></name><name><surname>Barron</surname><given-names>JJ</given-names></name><name><surname>Wade</surname><given-names>SD</given-names></name><name><surname>Cuevas</surname><given-names>B</given-names></name><name><surname>Vainchtein</surname><given-names>ID</given-names></name><name><surname>Silva</surname><given-names>NJ</given-names></name><name><surname>Guajardo</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Lidsky</surname><given-names>PV</given-names></name><name><surname>Wang</surname><given-names>EY</given-names></name><name><surname>Rivera</surname><given-names>BM</given-names></name><name><surname>Taloma</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Kaminskaya</surname><given-names>E</given-names></name><name><surname>Nakao-Inoue</surname><given-names>H</given-names></name><name><surname>Schwer</surname><given-names>B</given-names></name><name><surname>Arnold</surname><given-names>TD</given-names></name><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Condello</surname><given-names>C</given-names></name><name><surname>Andino</surname><given-names>R</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Molofsky</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Type-I-interferon-responsive microglia shape cortical development and behavior</article-title><source>Cell</source><volume>187</volume><fpage>1936</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2024.02.020</pub-id><pub-id pub-id-type="pmid">38490196</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Lundin</surname><given-names>S</given-names></name><name><surname>Käller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title><source>Bioinformatics</source><volume>32</volume><fpage>3047</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id><pub-id pub-id-type="pmid">27312411</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fites</surname><given-names>JS</given-names></name><name><surname>Gui</surname><given-names>M</given-names></name><name><surname>Kernien</surname><given-names>JF</given-names></name><name><surname>Negoro</surname><given-names>P</given-names></name><name><surname>Dagher</surname><given-names>Z</given-names></name><name><surname>Sykes</surname><given-names>DB</given-names></name><name><surname>Nett</surname><given-names>JE</given-names></name><name><surname>Mansour</surname><given-names>MK</given-names></name><name><surname>Klein</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An unappreciated role for neutrophil-DC hybrids in immunity to invasive fungal infections</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007073</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007073</pub-id><pub-id pub-id-type="pmid">29782541</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Canton</surname><given-names>J</given-names></name><name><surname>Furuya</surname><given-names>W</given-names></name><name><surname>Glogauer</surname><given-names>M</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis</article-title><source>Molecular Biology of the Cell</source><volume>25</volume><fpage>1511</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1091/mbc.E13-04-0212</pub-id><pub-id pub-id-type="pmid">24623723</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavazzi</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>CD</given-names></name><name><surname>Arnold</surname><given-names>K</given-names></name><name><surname>Swantkowski</surname><given-names>M</given-names></name><name><surname>Charlton</surname><given-names>L</given-names></name><name><surname>Modesti</surname><given-names>N</given-names></name><name><surname>Dar</surname><given-names>AA</given-names></name><name><surname>Vanderver</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Adang</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Nucleotide metabolism, leukodystrophies, and CNS pathology</article-title><source>Journal of Inherited Metabolic Disease</source><volume>47</volume><fpage>860</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1002/jimd.12721</pub-id><pub-id pub-id-type="pmid">38421058</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gosselin</surname><given-names>D</given-names></name><name><surname>Skola</surname><given-names>D</given-names></name><name><surname>Coufal</surname><given-names>NG</given-names></name><name><surname>Holtman</surname><given-names>IR</given-names></name><name><surname>Schlachetzki</surname><given-names>JCM</given-names></name><name><surname>Sajti</surname><given-names>E</given-names></name><name><surname>Jaeger</surname><given-names>BN</given-names></name><name><surname>O’Connor</surname><given-names>C</given-names></name><name><surname>Fitzpatrick</surname><given-names>C</given-names></name><name><surname>Pasillas</surname><given-names>MP</given-names></name><name><surname>Pena</surname><given-names>M</given-names></name><name><surname>Adair</surname><given-names>A</given-names></name><name><surname>Gonda</surname><given-names>DD</given-names></name><name><surname>Levy</surname><given-names>ML</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An environment-dependent transcriptional network specifies human microglia identity</article-title><source>Science</source><volume>356</volume><elocation-id>eaal3222</elocation-id><pub-id pub-id-type="doi">10.1126/science.aal3222</pub-id><pub-id pub-id-type="pmid">28546318</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gran</surname><given-names>S</given-names></name><name><surname>Honold</surname><given-names>L</given-names></name><name><surname>Fehler</surname><given-names>O</given-names></name><name><surname>Zenker</surname><given-names>S</given-names></name><name><surname>Eligehausen</surname><given-names>S</given-names></name><name><surname>Kuhlmann</surname><given-names>MT</given-names></name><name><surname>Geven</surname><given-names>E</given-names></name><name><surname>van den Bosch</surname><given-names>M</given-names></name><name><surname>van Lent</surname><given-names>P</given-names></name><name><surname>Spiekermann</surname><given-names>C</given-names></name><name><surname>Hermann</surname><given-names>S</given-names></name><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Schäfers</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Imaging, myeloid precursor immortalization, and genome editing for defining mechanisms of leukocyte recruitment <italic>in vivo</italic></article-title><source>Theranostics</source><volume>8</volume><fpage>2407</fpage><lpage>2423</lpage><pub-id pub-id-type="doi">10.7150/thno.23632</pub-id><pub-id pub-id-type="pmid">29721088</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Steinman</surname><given-names>RA</given-names></name><name><surname>Sheng</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>G</given-names></name><name><surname>Wiley</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An AGS-associated mutation in ADAR1 catalytic domain results in early-onset and MDA5-dependent encephalopathy with IFN pathway activation in the brain</article-title><source>Journal of Neuroinflammation</source><volume>19</volume><elocation-id>285</elocation-id><pub-id pub-id-type="doi">10.1186/s12974-022-02646-0</pub-id><pub-id pub-id-type="pmid">36457126</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurzeler</surname><given-names>U</given-names></name><name><surname>Rabachini</surname><given-names>T</given-names></name><name><surname>Dahinden</surname><given-names>CA</given-names></name><name><surname>Salmanidis</surname><given-names>M</given-names></name><name><surname>Brumatti</surname><given-names>G</given-names></name><name><surname>Ekert</surname><given-names>PG</given-names></name><name><surname>Echeverry</surname><given-names>N</given-names></name><name><surname>Bachmann</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>HU</given-names></name><name><surname>Kaufmann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vitro differentiation of near-unlimited numbers of functional mouse basophils using conditional Hoxb8</article-title><source>Allergy</source><volume>68</volume><fpage>604</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1111/all.12140</pub-id><pub-id pub-id-type="pmid">23590216</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haenseler</surname><given-names>W</given-names></name><name><surname>Sansom</surname><given-names>SN</given-names></name><name><surname>Buchrieser</surname><given-names>J</given-names></name><name><surname>Newey</surname><given-names>SE</given-names></name><name><surname>Moore</surname><given-names>CS</given-names></name><name><surname>Nicholls</surname><given-names>FJ</given-names></name><name><surname>Chintawar</surname><given-names>S</given-names></name><name><surname>Schnell</surname><given-names>C</given-names></name><name><surname>Antel</surname><given-names>JP</given-names></name><name><surname>Allen</surname><given-names>ND</given-names></name><name><surname>Cader</surname><given-names>MZ</given-names></name><name><surname>Wade-Martins</surname><given-names>R</given-names></name><name><surname>James</surname><given-names>WS</given-names></name><name><surname>Cowley</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response</article-title><source>Stem Cell Reports</source><volume>8</volume><fpage>1727</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2017.05.017</pub-id><pub-id pub-id-type="pmid">28591653</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>VX</given-names></name><name><surname>Mohammad</surname><given-names>SS</given-names></name><name><surname>Jones</surname><given-names>HF</given-names></name><name><surname>Bandodkar</surname><given-names>S</given-names></name><name><surname>Crow</surname><given-names>YJ</given-names></name><name><surname>Dale</surname><given-names>RC</given-names></name><collab>AGS-JAKi Study Group</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Cerebrospinal fluid neopterin as a biomarker of treatment response to Janus kinase inhibition in Aicardi-Goutières syndrome</article-title><source>Developmental Medicine and Child Neurology</source><volume>64</volume><fpage>266</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1111/dmcn.15025</pub-id><pub-id pub-id-type="pmid">34415581</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartner</surname><given-names>JC</given-names></name><name><surname>Schmittwolf</surname><given-names>C</given-names></name><name><surname>Kispert</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>AM</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>4894</fpage><lpage>4902</lpage><pub-id pub-id-type="doi">10.1074/jbc.M311347200</pub-id><pub-id pub-id-type="pmid">14615479</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasselmann</surname><given-names>J</given-names></name><name><surname>Coburn</surname><given-names>MA</given-names></name><name><surname>England</surname><given-names>W</given-names></name><name><surname>Figueroa Velez</surname><given-names>DX</given-names></name><name><surname>Kiani Shabestari</surname><given-names>S</given-names></name><name><surname>Tu</surname><given-names>CH</given-names></name><name><surname>McQuade</surname><given-names>A</given-names></name><name><surname>Kolahdouzan</surname><given-names>M</given-names></name><name><surname>Echeverria</surname><given-names>K</given-names></name><name><surname>Claes</surname><given-names>C</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Azevedo</surname><given-names>R</given-names></name><name><surname>Coufal</surname><given-names>NG</given-names></name><name><surname>Han</surname><given-names>CZ</given-names></name><name><surname>Cummings</surname><given-names>BJ</given-names></name><name><surname>Davtyan</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Healy</surname><given-names>LM</given-names></name><name><surname>Gandhi</surname><given-names>SP</given-names></name><name><surname>Spitale</surname><given-names>RC</given-names></name><name><surname>Blurton-Jones</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development of a chimeric model to study and manipulate human microglia in vivo</article-title><source>Neuron</source><volume>103</volume><fpage>1016</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.07.002</pub-id><pub-id pub-id-type="pmid">31375314</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiller</surname><given-names>B</given-names></name><name><surname>Achleitner</surname><given-names>M</given-names></name><name><surname>Glage</surname><given-names>S</given-names></name><name><surname>Naumann</surname><given-names>R</given-names></name><name><surname>Behrendt</surname><given-names>R</given-names></name><name><surname>Roers</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity</article-title><source>The Journal of Experimental Medicine</source><volume>209</volume><fpage>1419</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1084/jem.20120876</pub-id><pub-id pub-id-type="pmid">22802351</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>CCR2 overexpression promotes the efficient recruitment of retinal microglia in vitro</article-title><source>Molecular Vision</source><volume>18</volume><fpage>2982</fpage><lpage>2992</lpage><pub-id pub-id-type="pmid">23288990</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanazawa</surname><given-names>N</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Takita</surname><given-names>Y</given-names></name><name><surname>Nishikawa</surname><given-names>A</given-names></name><name><surname>Nishikomori</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)</article-title><source>Pediatric Rheumatology Online Journal</source><volume>21</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1186/s12969-023-00817-8</pub-id><pub-id pub-id-type="pmid">37087470</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lail</surname><given-names>SS</given-names></name><name><surname>Arnold</surname><given-names>CR</given-names></name><name><surname>de Almeida</surname><given-names>LGN</given-names></name><name><surname>McKenna</surname><given-names>N</given-names></name><name><surname>Chiriboga</surname><given-names>JA</given-names></name><name><surname>Dufour</surname><given-names>A</given-names></name><name><surname>Warren</surname><given-names>AL</given-names></name><name><surname>Yates</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Hox-driven conditional immortalization of myeloid and lymphoid progenitors: Uses, advantages, and future potential</article-title><source>Traffic</source><volume>23</volume><fpage>538</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1111/tra.12869</pub-id><pub-id pub-id-type="pmid">36117140</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Microglia and macrophages in brain homeostasis and disease</article-title><source>Nature Reviews. Immunology</source><volume>18</volume><fpage>225</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.125</pub-id><pub-id pub-id-type="pmid">29151590</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddicoat</surname><given-names>BJ</given-names></name><name><surname>Piskol</surname><given-names>R</given-names></name><name><surname>Chalk</surname><given-names>AM</given-names></name><name><surname>Ramaswami</surname><given-names>G</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><name><surname>Hartner</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>JB</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Walkley</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself</article-title><source>Science</source><volume>349</volume><fpage>1115</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1126/science.aac7049</pub-id><pub-id pub-id-type="pmid">26275108</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Gezer</surname><given-names>D</given-names></name><name><surname>Herrmann</surname><given-names>O</given-names></name><name><surname>Feldberg</surname><given-names>K</given-names></name><name><surname>Schemionek</surname><given-names>M</given-names></name><name><surname>Jawhar</surname><given-names>M</given-names></name><name><surname>Reiter</surname><given-names>A</given-names></name><name><surname>Brümmendorf</surname><given-names>TH</given-names></name><name><surname>Koschmieder</surname><given-names>S</given-names></name><name><surname>Chatain</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia</article-title><source>Molecular Carcinogenesis</source><volume>59</volume><fpage>87</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1002/mc.23131</pub-id><pub-id pub-id-type="pmid">31691359</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannion</surname><given-names>NM</given-names></name><name><surname>Greenwood</surname><given-names>SM</given-names></name><name><surname>Young</surname><given-names>R</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Brindle</surname><given-names>J</given-names></name><name><surname>Read</surname><given-names>D</given-names></name><name><surname>Nellåker</surname><given-names>C</given-names></name><name><surname>Vesely</surname><given-names>C</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>McLaughlin</surname><given-names>PJ</given-names></name><name><surname>Jantsch</surname><given-names>MF</given-names></name><name><surname>Dorin</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>IR</given-names></name><name><surname>Scadden</surname><given-names>ADJ</given-names></name><name><surname>Ohman</surname><given-names>M</given-names></name><name><surname>Keegan</surname><given-names>LP</given-names></name><name><surname>O’Connell</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The RNA-editing enzyme ADAR1 controls innate immune responses to RNA</article-title><source>Cell Reports</source><volume>9</volume><fpage>1482</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.041</pub-id><pub-id pub-id-type="pmid">25456137</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name><name><surname>Tozaki-Saitoh</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lentiviral transduction of cultured microglia</article-title><source>Methods in Molecular Biology</source><volume>1041</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-520-0_8</pub-id><pub-id pub-id-type="pmid">23813370</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>4288</fpage><lpage>4297</lpage><pub-id pub-id-type="doi">10.1093/nar/gks042</pub-id><pub-id pub-id-type="pmid">22287627</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Möller</surname><given-names>A</given-names></name><name><surname>Jauch-Speer</surname><given-names>S-L</given-names></name><name><surname>Gandhi</surname><given-names>S</given-names></name><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Fehler</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9</article-title><source>Frontiers in Immunology</source><volume>14</volume><elocation-id>1110185</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2023.1110185</pub-id><pub-id pub-id-type="pmid">37056775</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>M</given-names></name><name><surname>Stamp</surname><given-names>G</given-names></name><name><surname>Robins</surname><given-names>P</given-names></name><name><surname>Dulic</surname><given-names>A</given-names></name><name><surname>Rosewell</surname><given-names>I</given-names></name><name><surname>Hrivnak</surname><given-names>G</given-names></name><name><surname>Daly</surname><given-names>G</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name><name><surname>Barnes</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Gene-targeted mice lacking the Trex1 (DNase III) 3’--&gt;5’ DNA exonuclease develop inflammatory myocarditis</article-title><source>Molecular and Cellular Biology</source><volume>24</volume><fpage>6719</fpage><lpage>6727</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.15.6719-6727.2004</pub-id><pub-id pub-id-type="pmid">15254239</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muffat</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Mitalipova</surname><given-names>M</given-names></name><name><surname>Omer</surname><given-names>A</given-names></name><name><surname>Corcoran</surname><given-names>S</given-names></name><name><surname>Bakiasi</surname><given-names>G</given-names></name><name><surname>Tsai</surname><given-names>L-H</given-names></name><name><surname>Aubourg</surname><given-names>P</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Efficient derivation of microglia-like cells from human pluripotent stem cells</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1358</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1038/nm.4189</pub-id><pub-id pub-id-type="pmid">27668937</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Allen</surname><given-names>JE</given-names></name><name><surname>Biswas</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Goerdt</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Hamilton</surname><given-names>JA</given-names></name><name><surname>Ivashkiv</surname><given-names>LB</given-names></name><name><surname>Lawrence</surname><given-names>T</given-names></name><name><surname>Locati</surname><given-names>M</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>FO</given-names></name><name><surname>Mege</surname><given-names>J-L</given-names></name><name><surname>Mosser</surname><given-names>DM</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name><name><surname>Saeij</surname><given-names>JP</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Shirey</surname><given-names>KA</given-names></name><name><surname>Sica</surname><given-names>A</given-names></name><name><surname>Suttles</surname><given-names>J</given-names></name><name><surname>Udalova</surname><given-names>I</given-names></name><name><surname>van Ginderachter</surname><given-names>JA</given-names></name><name><surname>Vogel</surname><given-names>SN</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title><source>Immunity</source><volume>41</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><pub-id pub-id-type="pmid">25035950</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>CA</given-names></name><name><surname>Bennett</surname><given-names>FC</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microglia in antiviral immunity of the brain and spinal cord</article-title><source>Seminars in Immunology</source><volume>60</volume><elocation-id>101650</elocation-id><pub-id pub-id-type="doi">10.1016/j.smim.2022.101650</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohto</surname><given-names>T</given-names></name><name><surname>Tayeh</surname><given-names>AA</given-names></name><name><surname>Nishikomori</surname><given-names>R</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Arias-Loza</surname><given-names>A-P</given-names></name><name><surname>Soda</surname><given-names>N</given-names></name><name><surname>Satoh</surname><given-names>S</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Iizuka</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>N</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis</article-title><source>Journal of Autoimmunity</source><volume>127</volume><elocation-id>102794</elocation-id><pub-id pub-id-type="doi">10.1016/j.jaut.2022.102794</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>MJ</given-names></name><name><surname>Ichikawa</surname><given-names>DM</given-names></name><name><surname>Sedlock</surname><given-names>AB</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Johnson</surname><given-names>KR</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Elkahloun</surname><given-names>AG</given-names></name><name><surname>Maric</surname><given-names>D</given-names></name><name><surname>Sweeney</surname><given-names>CL</given-names></name><name><surname>Gossa</surname><given-names>S</given-names></name><name><surname>Malech</surname><given-names>HL</given-names></name><name><surname>McGavern</surname><given-names>DB</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differentiation of human and murine induced pluripotent stem cells to microglia-like cells</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>753</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1038/nn.4534</pub-id><pub-id pub-id-type="pmid">28253233</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira-Lopes</surname><given-names>S</given-names></name><name><surname>Celhar</surname><given-names>T</given-names></name><name><surname>Sans-Fons</surname><given-names>G</given-names></name><name><surname>Serra</surname><given-names>M</given-names></name><name><surname>Fairhurst</surname><given-names>A-M</given-names></name><name><surname>Lloberas</surname><given-names>J</given-names></name><name><surname>Celada</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The exonuclease Trex1 restrains macrophage proinflammatory activation</article-title><source>The Journal of Immunology</source><volume>191</volume><fpage>6128</fpage><lpage>6135</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301603</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priller</surname><given-names>J</given-names></name><name><surname>Flügel</surname><given-names>A</given-names></name><name><surname>Wehner</surname><given-names>T</given-names></name><name><surname>Boentert</surname><given-names>M</given-names></name><name><surname>Haas</surname><given-names>CA</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Fernández-Klett</surname><given-names>F</given-names></name><name><surname>Prass</surname><given-names>K</given-names></name><name><surname>Bechmann</surname><given-names>I</given-names></name><name><surname>de Boer</surname><given-names>BA</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name><name><surname>Kreutzberg</surname><given-names>GW</given-names></name><name><surname>Persons</surname><given-names>DA</given-names></name><name><surname>Dirnagl</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment</article-title><source>Nature Medicine</source><volume>7</volume><fpage>1356</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1038/nm1201-1356</pub-id><pub-id pub-id-type="pmid">11726978</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raschke</surname><given-names>WC</given-names></name><name><surname>Baird</surname><given-names>S</given-names></name><name><surname>Ralph</surname><given-names>P</given-names></name><name><surname>Nakoinz</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Functional macrophage cell lines transformed by Abelson leukemia virus</article-title><source>Cell</source><volume>15</volume><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(78)90101-0</pub-id><pub-id pub-id-type="pmid">212198</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2022">2022</year><data-title>R: a language and environment for statistical computing</data-title><version designator="4.5.2">4.5.2</version><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redecke</surname><given-names>V</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Finkelstein</surname><given-names>D</given-names></name><name><surname>Chaturvedi</surname><given-names>V</given-names></name><name><surname>High</surname><given-names>AA</given-names></name><name><surname>Häcker</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hematopoietic progenitor cell lines with myeloid and lymphoid potential</article-title><source>Nature Methods</source><volume>10</volume><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2510</pub-id><pub-id pub-id-type="pmid">23749299</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehwinkel</surname><given-names>J</given-names></name><name><surname>Maelfait</surname><given-names>J</given-names></name><name><surname>Bridgeman</surname><given-names>A</given-names></name><name><surname>Rigby</surname><given-names>R</given-names></name><name><surname>Hayward</surname><given-names>B</given-names></name><name><surname>Liberatore</surname><given-names>RA</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name><name><surname>Towers</surname><given-names>GJ</given-names></name><name><surname>Moita</surname><given-names>LF</given-names></name><name><surname>Crow</surname><given-names>YJ</given-names></name><name><surname>Bonthron</surname><given-names>DT</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SAMHD1-dependent retroviral control and escape in mice</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2454</fpage><lpage>2462</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.163</pub-id><pub-id pub-id-type="pmid">23872947</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>GI</given-names></name><name><surname>Del Toro Duany</surname><given-names>Y</given-names></name><name><surname>Jenkinson</surname><given-names>EM</given-names></name><name><surname>Forte</surname><given-names>GM</given-names></name><name><surname>Anderson</surname><given-names>BH</given-names></name><name><surname>Ariaudo</surname><given-names>G</given-names></name><name><surname>Bader-Meunier</surname><given-names>B</given-names></name><name><surname>Baildam</surname><given-names>EM</given-names></name><name><surname>Battini</surname><given-names>R</given-names></name><name><surname>Beresford</surname><given-names>MW</given-names></name><name><surname>Casarano</surname><given-names>M</given-names></name><name><surname>Chouchane</surname><given-names>M</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>AE</given-names></name><name><surname>Cordeiro</surname><given-names>NJ</given-names></name><name><surname>Dale</surname><given-names>RC</given-names></name><name><surname>Davidson</surname><given-names>JE</given-names></name><name><surname>De Waele</surname><given-names>L</given-names></name><name><surname>Desguerre</surname><given-names>I</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Fazzi</surname><given-names>E</given-names></name><name><surname>Isidor</surname><given-names>B</given-names></name><name><surname>Lagae</surname><given-names>L</given-names></name><name><surname>Latchman</surname><given-names>AR</given-names></name><name><surname>Lebon</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Livingston</surname><given-names>JH</given-names></name><name><surname>Lourenço</surname><given-names>CM</given-names></name><name><surname>Mancardi</surname><given-names>MM</given-names></name><name><surname>Masurel-Paulet</surname><given-names>A</given-names></name><name><surname>McInnes</surname><given-names>IB</given-names></name><name><surname>Menezes</surname><given-names>MP</given-names></name><name><surname>Mignot</surname><given-names>C</given-names></name><name><surname>O’Sullivan</surname><given-names>J</given-names></name><name><surname>Orcesi</surname><given-names>S</given-names></name><name><surname>Picco</surname><given-names>PP</given-names></name><name><surname>Riva</surname><given-names>E</given-names></name><name><surname>Robinson</surname><given-names>RA</given-names></name><name><surname>Rodriguez</surname><given-names>D</given-names></name><name><surname>Salvatici</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>C</given-names></name><name><surname>Szybowska</surname><given-names>M</given-names></name><name><surname>Tolmie</surname><given-names>JL</given-names></name><name><surname>Vanderver</surname><given-names>A</given-names></name><name><surname>Vanhulle</surname><given-names>C</given-names></name><name><surname>Vieira</surname><given-names>JP</given-names></name><name><surname>Webb</surname><given-names>K</given-names></name><name><surname>Whitney</surname><given-names>RN</given-names></name><name><surname>Williams</surname><given-names>SG</given-names></name><name><surname>Wolfe</surname><given-names>LA</given-names></name><name><surname>Zuberi</surname><given-names>SM</given-names></name><name><surname>Hur</surname><given-names>S</given-names></name><name><surname>Crow</surname><given-names>YJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling</article-title><source>Nature Genetics</source><volume>46</volume><fpage>503</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1038/ng.2933</pub-id><pub-id pub-id-type="pmid">24686847</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Righi</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>L</given-names></name><name><surname>De Libero</surname><given-names>G</given-names></name><name><surname>Sironi</surname><given-names>M</given-names></name><name><surname>Biondi</surname><given-names>A</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Donini</surname><given-names>SD</given-names></name><name><surname>Ricciardi-Castagnoli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Monokine production by microglial cell clones</article-title><source>European Journal of Immunology</source><volume>19</volume><fpage>1443</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1002/eji.1830190815</pub-id><pub-id pub-id-type="pmid">2789141</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Research</source><volume>43</volume><elocation-id>e47</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AW</given-names></name><name><surname>Popov</surname><given-names>LM</given-names></name><name><surname>Mitchell</surname><given-names>G</given-names></name><name><surname>Ching</surname><given-names>KL</given-names></name><name><surname>Licht</surname><given-names>DJ</given-names></name><name><surname>Golovkine</surname><given-names>G</given-names></name><name><surname>Barton</surname><given-names>GM</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cas9<sup>+</sup> conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond</article-title><source>eLife</source><volume>8</volume><elocation-id>e45957</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45957</pub-id><pub-id pub-id-type="pmid">31204998</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosas</surname><given-names>M</given-names></name><name><surname>Osorio</surname><given-names>F</given-names></name><name><surname>Robinson</surname><given-names>MJ</given-names></name><name><surname>Davies</surname><given-names>LC</given-names></name><name><surname>Dierkes</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cells</article-title><source>European Journal of Immunology</source><volume>41</volume><fpage>356</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1002/eji.201040962</pub-id><pub-id pub-id-type="pmid">21268006</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname><given-names>MW</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microglia emerge as central players in brain disease</article-title><source>Nature Medicine</source><volume>23</volume><fpage>1018</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1038/nm.4397</pub-id><pub-id pub-id-type="pmid">28886007</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>VA</given-names></name><name><surname>Graves-Lindsay</surname><given-names>T</given-names></name><name><surname>Howe</surname><given-names>K</given-names></name><name><surname>Bouk</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>H-C</given-names></name><name><surname>Kitts</surname><given-names>PA</given-names></name><name><surname>Murphy</surname><given-names>TD</given-names></name><name><surname>Pruitt</surname><given-names>KD</given-names></name><name><surname>Thibaud-Nissen</surname><given-names>F</given-names></name><name><surname>Albracht</surname><given-names>D</given-names></name><name><surname>Fulton</surname><given-names>RS</given-names></name><name><surname>Kremitzki</surname><given-names>M</given-names></name><name><surname>Magrini</surname><given-names>V</given-names></name><name><surname>Markovic</surname><given-names>C</given-names></name><name><surname>McGrath</surname><given-names>S</given-names></name><name><surname>Steinberg</surname><given-names>KM</given-names></name><name><surname>Auger</surname><given-names>K</given-names></name><name><surname>Chow</surname><given-names>W</given-names></name><name><surname>Collins</surname><given-names>J</given-names></name><name><surname>Harden</surname><given-names>G</given-names></name><name><surname>Hubbard</surname><given-names>T</given-names></name><name><surname>Pelan</surname><given-names>S</given-names></name><name><surname>Simpson</surname><given-names>JT</given-names></name><name><surname>Threadgold</surname><given-names>G</given-names></name><name><surname>Torrance</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>JM</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Koren</surname><given-names>S</given-names></name><name><surname>Boitano</surname><given-names>M</given-names></name><name><surname>Peluso</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Chin</surname><given-names>C-S</given-names></name><name><surname>Phillippy</surname><given-names>AM</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Church</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly</article-title><source>Genome Research</source><volume>27</volume><fpage>849</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1101/gr.213611.116</pub-id><pub-id pub-id-type="pmid">28396521</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shemer</surname><given-names>A</given-names></name><name><surname>Grozovski</surname><given-names>J</given-names></name><name><surname>Tay</surname><given-names>TL</given-names></name><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Volaski</surname><given-names>A</given-names></name><name><surname>Süß</surname><given-names>P</given-names></name><name><surname>Ardura-Fabregat</surname><given-names>A</given-names></name><name><surname>Gross-Vered</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>J-S</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Chappell-Maor</surname><given-names>L</given-names></name><name><surname>Thielecke</surname><given-names>L</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Cornils</surname><given-names>K</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>5206</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-07548-5</pub-id><pub-id pub-id-type="pmid">30523248</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>RZ</given-names></name><name><surname>Prohaska</surname><given-names>TA</given-names></name><name><surname>Hoeksema</surname><given-names>MA</given-names></name><name><surname>Spann</surname><given-names>NJ</given-names></name><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Fonseca</surname><given-names>GJ</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Stolze</surname><given-names>LK</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Romanoski</surname><given-names>CE</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Systematic analysis of naturally occurring insertions and deletions that alter transcription factor spacing identifies tolerant and sensitive transcription factor pairs</article-title><source>eLife</source><volume>11</volume><elocation-id>e70878</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70878</pub-id><pub-id pub-id-type="pmid">35049498</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Research</source><volume>4</volume><elocation-id>75631</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Heard</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Factors regulating macrophage production and growth: purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells</article-title><source>The Journal of Biological Chemistry</source><volume>252</volume><fpage>4305</fpage><lpage>4312</lpage><pub-id pub-id-type="pmid">301140</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Sopher</surname><given-names>B</given-names></name><name><surname>Gillespie</surname><given-names>J</given-names></name><name><surname>Aloi</surname><given-names>MS</given-names></name><name><surname>Odom</surname><given-names>GL</given-names></name><name><surname>Hopkins</surname><given-names>S</given-names></name><name><surname>Case</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>DB</given-names></name><name><surname>Chamberlain</surname><given-names>JS</given-names></name><name><surname>Garden</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Recombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microglia</article-title><source>Journal of Neurochemistry</source><volume>1</volume><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/jnc.13081</pub-id><pub-id pub-id-type="pmid">25708596</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>K</given-names></name><name><surname>Kozaki</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>CZW</given-names></name><name><surname>Thion</surname><given-names>MS</given-names></name><name><surname>Otsuka</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Utami</surname><given-names>KH</given-names></name><name><surname>Fidan</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>DS</given-names></name><name><surname>Malleret</surname><given-names>B</given-names></name><name><surname>Chakarov</surname><given-names>S</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><name><surname>Low</surname><given-names>G</given-names></name><name><surname>Garcia-Miralles</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Goh</surname><given-names>CC</given-names></name><name><surname>Gul</surname><given-names>A</given-names></name><name><surname>Hubert</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Low</surname><given-names>I</given-names></name><name><surname>Shadan</surname><given-names>NB</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>TS</given-names></name><name><surname>Mok</surname><given-names>E</given-names></name><name><surname>Kawanishi</surname><given-names>S</given-names></name><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Larbi</surname><given-names>A</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Renia</surname><given-names>L</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Wolf</surname><given-names>Y</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Önder</surname><given-names>T</given-names></name><name><surname>Newell</surname><given-names>E</given-names></name><name><surname>Huber</surname><given-names>T</given-names></name><name><surname>Ashihara</surname><given-names>E</given-names></name><name><surname>Garel</surname><given-names>S</given-names></name><name><surname>Pouladi</surname><given-names>MA</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function</article-title><source>Immunity</source><volume>52</volume><fpage>417</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.01.004</pub-id><pub-id pub-id-type="pmid">32075730</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmerman</surname><given-names>R</given-names></name><name><surname>Burm</surname><given-names>SM</given-names></name><name><surname>Bajramovic</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An overview of in vitro methods to study microglia</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>242</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00242</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>S</given-names></name><name><surname>Yamabe</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Konno</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)</article-title><source>International Journal of Cancer</source><volume>26</volume><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910260208</pub-id><pub-id pub-id-type="pmid">6970727</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderver</surname><given-names>A</given-names></name><name><surname>Adang</surname><given-names>L</given-names></name><name><surname>Gavazzi</surname><given-names>F</given-names></name><name><surname>McDonald</surname><given-names>K</given-names></name><name><surname>Helman</surname><given-names>G</given-names></name><name><surname>Frank</surname><given-names>DB</given-names></name><name><surname>Jaffe</surname><given-names>N</given-names></name><name><surname>Yum</surname><given-names>SW</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>SR</given-names></name><name><surname>Lebon</surname><given-names>P</given-names></name><name><surname>Meritet</surname><given-names>J-F</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Takanohashi</surname><given-names>A</given-names></name><name><surname>Armangue</surname><given-names>T</given-names></name><name><surname>Ulrick</surname><given-names>N</given-names></name><name><surname>Sherbini</surname><given-names>O</given-names></name><name><surname>Koh</surname><given-names>J</given-names></name><name><surname>Peer</surname><given-names>K</given-names></name><name><surname>Besnier</surname><given-names>C</given-names></name><name><surname>Scher</surname><given-names>C</given-names></name><name><surname>Boyle</surname><given-names>K</given-names></name><name><surname>Dubbs</surname><given-names>H</given-names></name><name><surname>Kramer-Golinkoff</surname><given-names>J</given-names></name><name><surname>Pizzino</surname><given-names>A</given-names></name><name><surname>Woidill</surname><given-names>S</given-names></name><name><surname>Shults</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Janus kinase inhibition in the aicardi-goutières syndrome</article-title><source>The New England Journal of Medicine</source><volume>383</volume><fpage>986</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2001362</pub-id><pub-id pub-id-type="pmid">32877590</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>GG</given-names></name><name><surname>Calvo</surname><given-names>KR</given-names></name><name><surname>Pasillas</surname><given-names>MP</given-names></name><name><surname>Sykes</surname><given-names>DB</given-names></name><name><surname>Häcker</surname><given-names>H</given-names></name><name><surname>Kamps</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8</article-title><source>Nature Methods</source><volume>3</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1038/nmeth865</pub-id><pub-id pub-id-type="pmid">16554834</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>SV</given-names></name><name><surname>George</surname><given-names>CX</given-names></name><name><surname>Welch</surname><given-names>MJ</given-names></name><name><surname>Liou</surname><given-names>L-Y</given-names></name><name><surname>Hahm</surname><given-names>B</given-names></name><name><surname>Lewicki</surname><given-names>H</given-names></name><name><surname>de la Torre</surname><given-names>JC</given-names></name><name><surname>Samuel</surname><given-names>CE</given-names></name><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis</article-title><source>PNAS</source><volume>108</volume><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1073/pnas.1017241108</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Ggplot2</data-title><version designator="4.0.1">4.0.1</version><source>Posit Software</source><ext-link ext-link-type="uri" xlink:href="https://ggplot2.tidyverse.org">https://ggplot2.tidyverse.org</ext-link></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>AP</given-names></name><name><surname>Vale</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spatial control of Draper receptor signaling initiates apoptotic cell engulfment</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>3977</fpage><lpage>3992</lpage><pub-id pub-id-type="doi">10.1083/jcb.201711175</pub-id><pub-id pub-id-type="pmid">30139739</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>JJ</given-names></name><name><surname>Chalk</surname><given-names>AM</given-names></name><name><surname>Nikolic</surname><given-names>I</given-names></name><name><surname>Simpson</surname><given-names>KJ</given-names></name><name><surname>Smeets</surname><given-names>MF</given-names></name><name><surname>Walkley</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation</article-title><source>Blood Advances</source><volume>6</volume><fpage>2092</fpage><lpage>2106</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2021004571</pub-id><pub-id pub-id-type="pmid">34464972</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>XuFeng</surname><given-names>R</given-names></name><name><surname>Boyer</surname><given-names>MJ</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ADAR1 is required for hematopoietic progenitor cell survival via RNA editing</article-title><source>PNAS</source><volume>106</volume><fpage>17763</fpage><lpage>17768</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903324106</pub-id><pub-id pub-id-type="pmid">19805087</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zach</surname><given-names>F</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Gessner</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Production and functional characterization of murine osteoclasts differentiated from ER-Hoxb8-immortalized myeloid progenitor cells</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0142211</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0142211</pub-id><pub-id pub-id-type="pmid">26529319</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbino</surname><given-names>DR</given-names></name><name><surname>Achuthan</surname><given-names>P</given-names></name><name><surname>Akanni</surname><given-names>W</given-names></name><name><surname>Amode</surname><given-names>MR</given-names></name><name><surname>Barrell</surname><given-names>D</given-names></name><name><surname>Bhai</surname><given-names>J</given-names></name><name><surname>Billis</surname><given-names>K</given-names></name><name><surname>Cummins</surname><given-names>C</given-names></name><name><surname>Gall</surname><given-names>A</given-names></name><name><surname>Girón</surname><given-names>CG</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Gordon</surname><given-names>L</given-names></name><name><surname>Haggerty</surname><given-names>L</given-names></name><name><surname>Haskell</surname><given-names>E</given-names></name><name><surname>Hourlier</surname><given-names>T</given-names></name><name><surname>Izuogu</surname><given-names>OG</given-names></name><name><surname>Janacek</surname><given-names>SH</given-names></name><name><surname>Juettemann</surname><given-names>T</given-names></name><name><surname>To</surname><given-names>JK</given-names></name><name><surname>Laird</surname><given-names>MR</given-names></name><name><surname>Lavidas</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Loveland</surname><given-names>JE</given-names></name><name><surname>Maurel</surname><given-names>T</given-names></name><name><surname>McLaren</surname><given-names>W</given-names></name><name><surname>Moore</surname><given-names>B</given-names></name><name><surname>Mudge</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>DN</given-names></name><name><surname>Newman</surname><given-names>V</given-names></name><name><surname>Nuhn</surname><given-names>M</given-names></name><name><surname>Ogeh</surname><given-names>D</given-names></name><name><surname>Ong</surname><given-names>CK</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Patricio</surname><given-names>M</given-names></name><name><surname>Riat</surname><given-names>HS</given-names></name><name><surname>Schuilenburg</surname><given-names>H</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Sparrow</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Thormann</surname><given-names>A</given-names></name><name><surname>Vullo</surname><given-names>A</given-names></name><name><surname>Walts</surname><given-names>B</given-names></name><name><surname>Zadissa</surname><given-names>A</given-names></name><name><surname>Frankish</surname><given-names>A</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Kostadima</surname><given-names>M</given-names></name><name><surname>Langridge</surname><given-names>N</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Muffato</surname><given-names>M</given-names></name><name><surname>Perry</surname><given-names>E</given-names></name><name><surname>Ruffier</surname><given-names>M</given-names></name><name><surname>Staines</surname><given-names>DM</given-names></name><name><surname>Trevanion</surname><given-names>SJ</given-names></name><name><surname>Aken</surname><given-names>BL</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ensembl 2018</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D754</fpage><lpage>D761</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1098</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sloan</surname><given-names>SA</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Scholze</surname><given-names>AR</given-names></name><name><surname>O’Keeffe</surname><given-names>S</given-names></name><name><surname>Phatnani</surname><given-names>HP</given-names></name><name><surname>Guarnieri</surname><given-names>P</given-names></name><name><surname>Caneda</surname><given-names>C</given-names></name><name><surname>Ruderisch</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>11929</fpage><lpage>11947</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id><pub-id pub-id-type="pmid">25186741</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>L-S</given-names></name><name><surname>Kaneko</surname><given-names>N</given-names></name><name><surname>Sawamoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice</article-title><source>Frontiers in Cellular Neuroscience</source><volume>9</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2015.00005</pub-id><pub-id pub-id-type="pmid">25674053</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102900.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ginhoux</surname><given-names>Florent</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Singapore Immunology Network</institution><country>Singapore</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Exceptional</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This revised study describes an <bold>important</bold> new model for in vivo manipulation of microglia, exploring how mutations in the Adar1 gene within microglia contribute to Aicardi-Goutières Syndome. The methodology is validated with <bold>exceptional</bold> data, supporting the authors' conclusions. The paper underscores both the advantages and limitations of using transplanted cells as a surrogate for microglia, making it a resource that is of value for biologists studying macrophages and microglia.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102900.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Aicardi-Goutières Syndrome (AGS) is a genetic disorder that primarily affects the brain and immune system through excessive interferon production. The authors sought to investigate the role of microglia in AGS by first developing bone-marrow-derived progenitors in vitro that carry the estrogen-regulated (ER) Hoxb8 cassette, allowing them to expand indefinitely in the presence of estrogen and differentiate into macrophages when estrogen is removed. When injected into the brains of Csf1r-/- mice, which lack microglia, these cells engraft and resemble wild-type (WT) microglia in transcriptional and morphological characteristics, although they lack Sall1 expression. The authors then generated CRISPR-Cas9 Adar1 knockout (KO) ER-Hoxb8 macrophages, which exhibited increased production of inflammatory cytokines and upregulation of interferon-related genes. This phenotype could be rescued using a Jak-Stat inhibitor or by concurrently mutating Ifih1 (Mda5). However, these Adar1-KO macrophages fail to successfully engraft in the brain of both Csf1r-/- and Cx3cr1-creERT2:Csf1rfl/fl mice. To overcome this, the authors used a mouse model with a patient-specific Adar1 mutation (Adar1 D1113H) to derive ER-Hoxb8 bone marrow progenitors and macrophages. They discovered that Adar1 D1113H ER-Hoxb8 macrophages successfully engraft the brain, although at lower levels than WT-derived ER-Hoxb8 macrophages, leading to increased production of Isg15 by neighboring cells. These findings shed new light on the role of microglia in AGS pathology.</p><p>Strengths:</p><p>The authors convincingly demonstrate that ER-Hoxb8 differentiated macrophages are transcriptionally and morphologically similar to bone marrow-derived macrophages. They also show evidence that when engrafted in vivo, ER-Hoxb8 microglia are transcriptomically similar to WT microglia. Furthermore, ER-Hoxb8 macrophages engraft the Csf1r-/- brain with high efficiency and rapidly (2 weeks), showing a homogenous distribution. The authors also effectively use CRISPR-Cas9 to knock out TLR4 in these cells with little to no effect on their engraftment in vivo, confirming their potential as a model for genetic manipulation and in vivo microglia replacement.</p><p>Overall, this paper demonstrates an innovative approach to manipulating microglia using ER-Hoxb8 cells as surrogates. The authors present convincing evidence of the model's efficacy and potential for broader application in microglial research, given its ease of production and rapid brain engraftment potential in microglia-deficient mice. Using mouse-derived cells for transplantation reduces complications that can come with the use of human cell lines, highlighting the utility of this system for research in mouse models.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102900.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Microglia have been implicated in brain development, homeostasis, and diseases. &quot;Microglia replacement&quot; has gain tractions in recent years, using primary microglia, bone marrow or blood-derived myeloid cells, or human iPSC-induced microglia. Here, the authors extended their previous work in the area and provide evidence to support: (1) Estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized macrophages from bone marrow can serve as stable, genetically manipulated cell lines. These cells are highly comparable to primary bone marrow-derived (BMD) macrophages in vitro, and, when transplanted into a microglia-free brain, engraft the parenchyma and differentiate into microglia-like cells (MLCs). Taking advantage of this model system, the authors created stable, Adar1-mutated ER-Hoxb8 lines using CRISPR-Cas9 to study the intrinsic contribution of macrophages to Aicardi-Goutières Syndrome (AGS) disease mechanism.</p><p>Strengths:</p><p>The studies are carefully designed and well-conducted. The imaging data and gene expression analysis are carried out at a high level of technical competences and the studies provide strong evidence that ER-Hoxb8 immortalized macrophages from bone marrow are a reasonable source for &quot;microglia replacement&quot; exercise. The findings are clearly presented, and the main message will be of general interest to the neuroscience and microglia communities.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.102900.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nemec</surname><given-names>Kelsey M</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Uy</surname><given-names>Genevieve</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Chaluvadi</surname><given-names>V Sai</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Purnell</surname><given-names>Freddy S</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Elfayoumi</surname><given-names>Bilal</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Byerly</surname><given-names>Leila</given-names></name><role specific-use="author">Author</role><aff><institution>Bryn Mawr College</institution><addr-line><named-content content-type="city">Bryn Mawr</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>O'Reilly</surname><given-names>Micaela L</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Carleigh</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Aisenberg</surname><given-names>William H</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Lombroso</surname><given-names>Sonia I</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xinfeng</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pittsburgh</institution><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Blank</surname><given-names>Niklas</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Oon</surname><given-names>Chet Huan</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Yaqoob</surname><given-names>Fazeela</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Temsamrit</surname><given-names>Brian</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Rawat</surname><given-names>Priyanka</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Thaiss</surname><given-names>Christoph</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bailis</surname><given-names>Will</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Williamson</surname><given-names>Adam P</given-names></name><role specific-use="author">Author</role><aff><institution>Bryn Mawr College</institution><addr-line><named-content content-type="city">Bryn Mawr</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qingde</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pittsburgh</institution><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bennett</surname><given-names>Mariko L</given-names></name><role specific-use="author">Author</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01z7r7q48</institution-id><institution>Children's Hospital of Philadelphia</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Bennett</surname><given-names>F Chris</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>Aicardi-Goutières Syndrome (AGS) is a genetic disorder that primarily affects the brain and immune system through excessive interferon production. The authors sought to investigate the role of microglia in AGS by first developing bone-marrow-derived progenitors in vitro that carry the estrogen-regulated (ER) Hoxb8 cassette, allowing them to expand indefinitely in the presence of estrogen and differentiate into macrophages when estrogen is removed. When injected into the brains of Csf1r-/- mice, which lack microglia, these cells engraft and resemble wild-type (WT) microglia in transcriptional and morphological characteristics, although they lack Sall1 expression. The authors then generated CRISPR-Cas9 Adar1 knockout (KO) ER-Hoxb8 macrophages, which exhibited increased production of inflammatory cytokines and upregulation of interferon-related genes. This phenotype could be rescued using a Jak-Stat inhibitor or by concurrently mutating Ifih1 (Mda5). However, these Adar1-KO macrophages fail to successfully engraft in the brain of both Csf1r-/- and Cx3cr1-creERT2:Csf1rfl/fl mice. To overcome this, the authors used a mouse model with a patient-specific Adar1 mutation (Adar1 D1113H) to derive ER-Hoxb8 bone marrow progenitors and macrophages. They discovered that Adar1 D1113H ER-Hoxb8 macrophages successfully engraft the brain, although at lower levels than WT-derived ER-Hoxb8 macrophages, leading to increased production of Isg15 by neighboring cells. These findings shed new light on the role of microglia in AGS pathology.</p><p>Strengths:</p><p>The authors convincingly demonstrate that ER-Hoxb8 differentiated macrophages are transcriptionally and morphologically similar to bone marrow-derived macrophages. They also show evidence that when engrafted in vivo, ER-Hoxb8 microglia are transcriptomically similar to WT microglia. Furthermore, ER-Hoxb8 macrophages engraft the Csf1r-/- brain with high efficiency and rapidly (2 weeks), showing a homogenous distribution. The authors also effectively use CRISPR-Cas9 to knock out TLR4 in these cells with little to no effect on their engraftment in vivo, confirming their potential as a model for genetic manipulation and in vivo microglia replacement.</p><p>Weaknesses:</p><p>The robust data showing the quality of this model at the transcriptomic level can be strengthened with confirmation at protein and functional levels. The authors were unable to investigate the effects of Adar1-KO using ER-Hoxb8 cells and instead had to rely on a mouse model with a patient-specific Adar1 mutation (Adar1 D1113H). Additionally, ER-Hoxb8-derived microglia do not express Sall1, a key marker of microglia, which limits their fidelity as a full microglial replacement, as has been rightfully pointed out in the discussion.</p><p>Overall, this paper demonstrates an innovative approach to manipulating microglia using ER-Hoxb8 cells as surrogates. The authors present convincing evidence of the model's efficacy and potential for broader application in microglial research, given its ease of production and rapid brain engraftment potential in microglia-deficient mice. While Adar1-KO macrophages do not engraft well, the success of TLR4-KO line highlights the model's potential for investigating other genes. Using mouse-derived cells for transplantation reduces complications that can come with the use of human cell lines, highlighting the utility of this system for research in mouse models.</p></disp-quote><p>Thank you for this thoughtful and balanced assessment. The major suggestion from Reviewer 1 was that confirmation of RNAseq data with protein or functional studies would add strength. We provided protein staining by IHC for IBA1 in vivo, as well as protein staining by FACS for CD11B, CD45, and TMEM119 in vitro and in vivo. For TLR4, we showed successful protein KO and blunted response to LPS (a TLR4 ligand) challenge, which we believe provides some protein and functional data to support the approach. To bolster these data, we added staining for P2RY12 on brain-engrafted ER-Hoxb8s.</p><p>Regarding the <italic>Adar1</italic> KO phenotypes showing non-engraftment. Because ADAR1 KO mice are embryonically lethal due to hematopoietic failure, we see the health impacts of <italic>Adar1</italic> KO on ER-Hoxb8s as a strength of the transplantation model, enabling the assessment of ADAR1 global function in macrophages and microglia-like cells without generation of a transgenic mouse line. In addition, it was a surprise that the health impact occurs at the macrophage and not the progenitor stage, perhaps providing insight for future studies of ADAR1’s role in hematopoiesis. Instead, we were able to show a significant impact of complete loss of <italic>Adar1</italic> on survival and engraftment, suggesting an important biological function of ADAR1. Macrophage-specific D1113H mutation, which affects part of the deaminase domain, shows that when the RNA deamination (but not the RNA binding) function of ADAR1 is disrupted, we find brain-wide interferonopathy. This is very exciting to our group and hopefully the community as astrocytes are thought to be a major driver of brain interferonopathy in patients with ADAR1 mutations. Instead, this suggests that disruption of brain macrophages is also a major contributor.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>Microglia have been implicated in brain development, homeostasis, and diseases. &quot;Microglia replacement&quot; has gained traction in recent years, using primary microglia, bone marrow or blood-derived myeloid cells, or human iPSC-induced microglia. Here, the authors extended their previous work in the area and provided evidence to support: (1)</p><p>Estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized macrophages from bone marrow can serve as stable, genetically manipulated cell lines. These cells are highly comparable to primary bone marrow-derived (BMD) macrophages in vitro, and, when transplanted into a microglia-free brain, engraft the parenchyma and differentiate into microglia-like cells (MLCs). Taking advantage of this model system, the authors created stable, Adar1-mutated ER-Hoxb8 lines using CRISPR-Cas9 to study the intrinsic contribution of macrophages to the Aicardi-Goutières Syndrome (AGS) disease mechanism.</p><p>Strengths:</p><p>The studies are carefully designed and well-conducted. The imaging data and gene expression analysis are carried out at a high level of technical competence and the studies provide strong evidence that ER-Hoxb8 immortalized macrophages from bone marrow are a reasonable source for &quot;microglia replacement&quot; exercise. The findings are clearly presented, and the main message will be of general interest to the neuroscience and microglia communities.</p><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>This is an elegant study, demonstrating both the utility and limitations of ER-Hoxb8 technology as a surrogate model for microglia in vivo. The manuscript is well-designed and clearly written, but authors should consider the following suggestions:</p><p>(1) Validation of RNA hits at the protein level: To strengthen the comparison between ER-Hoxb8 macrophages and WT bone marrow-derived macrophages, validating several RNA hits at the protein level would be beneficial. As many of these hits are surface markers, flow cytometry could be employed for confirmation (e.g., Figure 1D, Figure 3E).</p></disp-quote><p>In vitro, we show protein levels by flow cytometry for CD11B (ITGAM) and CD45 (PTPRC; Figure 1C), as well as TMEM119 (Supplemental Figure 2A) and TLR4 (Supplemental Figure 3C/D). In vivo, we show TMEM119 protein levels by flow cytometry (Figure 3A), as well as their CD11B/CD45 pregates (Supplemental Figure 2C), plus immunostaining for IBA1 (AIF1; Figure 2D). We now provide additional data showing P2RY12 immunostaining in brain-engrafted cells (Supplemental Figure 2B).</p><disp-quote content-type="editor-comment"><p>(2) The authors should consider testing the phagocytic capacity of ER-Hoxb8-derived macrophages to further validate their functionality.</p></disp-quote><p>Thank you for the suggestion. We measured ER-Hoxb8 macrophage ability to engulf phosphatidylserine-coated beads that mimic apoptotic cells, compared with phosphatidylcholine-coated beads, now as new Supplemental Figure 1C/D. This agrees with existing literature showing efficient engulfment/phagocytosis by ER-Hoxb8-derived cells (Elhag et al., 2021).</p><disp-quote content-type="editor-comment"><p>(3) For Figure 3E, incorporating a wild-type (WT) microglia reference would be beneficial to establish a baseline for comparison (e.g. including WT microglia data in the graph or performing a ratio analysis against WT expression levels).</p></disp-quote><p>We agree - we now include bars representing our sequenced primary microglia data in Figure 3E as a comparison.</p><disp-quote content-type="editor-comment"><p>(4) Some statistical analyses may require refinement. Specifically, for Figure 4J, where the effects of Adar1 KO and Adar1 KO with Bari are compared, it would be more appropriate to use a two-way ANOVA.</p></disp-quote><p>Thank you for noting it. We have now done more appropriate two-way ANOVA and included the updated results in Figure 4J and the corresponding Supplemental Figure 4G. Errors in figure legend texts have also been corrected to reflect the statistical tests used.</p><disp-quote content-type="editor-comment"><p>(5) Cx3cr1-creERT2 pups injected with tamoxifen: The authors could clarify the depletion ratio in these experiments before the engraftment and assess whether the depletion is global or regional. In comparison to Csf1r-/-, where TLR4-KO ER-Hoxb8 engraft globally, in Cx3cr1-creERT2, the engraftment seems more regional (Figure 5A vs Supplementary Figure 5B); is this due to the differences in depletion efficiency?</p></disp-quote><p>This is an excellent question and observation, and one that we are very interested in, though that finding does not change the conclusions of this particular study. We find some region-specific differences in depletion early after tamoxifen injection, but that all brain regions are &gt;95% depleted by P7. For instance, in a recently published manuscript (Bastos et al., 2025) we find some differences in the depletion kinetics in the genetic model. By P3, we find 90% depletion in cortex with 50-60% in thalamus and hippocampus. In other studies, we typically deliver primary monocytes, and this is the first study where we report engraftment of ER-Hoxb8 cells in the inducible model. In this sense, it is possible that depletion kinetics may regionally affect engraftment, but future studies are required to more finely assess this point with ER-Hoxb8s, as it may change how these models are used in the future.</p><p>Bastos et al., Monocytes can efficiently replace all brain macrophages and fetal liver monocytes can generate bonafide SALL1+ microglia, Immunity (2025), <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2025.04.006">https://doi.org/10.1016/j.immuni.2025.04.006</ext-link></p><disp-quote content-type="editor-comment"><p>(6) It would be helpful for the authors to clarify whether Adar1 is predominantly expressed by microglia, especially since the study aims to show its role in dampening the interferon response.</p></disp-quote><p>That’s a wonderful point. <italic>Adar1</italic> is expressed by all brain cells, with highest transcript level in some neurons, astrocytes, and oligodendrocytes. It is an interferon-stimulated gene, and mutation itself leads to interferonopathy, we believe, due to poor RNA editing and detection of endogenous RNA as non-self by MDA5. We hope it can dampen the interferon response, but in the case of mutation, <italic>Adar1</italic> is probably causal of interferonopathy. It is induced in microglia upon systemic inflammatory challenge (LPS). We have edited the text to highlight its expression pattern. See BrainRNAseq.org (Zhang*, Chen*, Sloan*, et al., 2014 and Bennett et al., 2016)</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) There appears to be a morphological difference between wt and Adar1/Ifih1 double KO (dKO) cells in the engrafted brains (Figure 5). It would be good if the authors could systematically compare the morphology (e.g., soma size, number, and length of branches) of the engrafted MLCs between the wt and mutant cells.</p></disp-quote><p>We agree. While cells did not differ in branch number or length, engrafted dKO cells had significantly larger somas compared with controls, which we now present in Figure S5A.</p><disp-quote content-type="editor-comment"><p>(2) To fully appreciate the extent of how those engrafted ER-Hoxb8 immortalized macrophages resemble primary, engrafted yolk sac-myeloid cells, vs engrafted iPSC-induced microglia, it would be informative to provide a comparison of their RNAseq data derived from the engrafted ER-Hoxb8 immortalized macrophages with published data transcriptomic data sets (e.g. Bennett et al. Neuron 2018; Chadarevian et al. Neuron 2024; Schafer et al. Cell 2023).</p></disp-quote><p>Thank you for this suggestion. To address this, we provide our full dataset for additional experiments. To compare with a similar non-immortalized model, we compared top up- and down-regulated genes from our data to those of ICT yolk sac progenitor cells from our previous work (Bennett et al., 2018). We find overlap between brain-engrafted ER-Hoxb8-, bone marrow-, and yolk sac-derived cells (Supplemental Figure 2F, Supplemental Table 3).</p><disp-quote content-type="editor-comment"><p>Minor comments:</p><p>Figure 6C: red arrow showing zoom in regions are not matchable. It might be beneficial to provide bigger images with each channel for C and D as a Supplemental Figure.</p></disp-quote><p>We fixed this in Figure 6C to show areas of interest in the cortex for both conditions. Figure S7A shows intermediate power images to aid in interpretation.</p></body></sub-article></article>